TSS:Rfhg 138071.1

Basic information about the TSS

---

TSS ID: rfhg_138071.1 Species: human Chr: chr11		Start: 62727589 End: 62727599 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2456784,EH38E1542845)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC029105:117 GeneID: 221092 HGNC/MGI_ID: HGNC:25451 UniProt_ID: Nearer transcript ids and distances:

Gene_name: HNRNPUL2 Gene_symbol: HNRNPUL2 Gene_synonyms: DKFZp762N1910 Gene_source: HGNC:25451

TATA-Box annotation

---

Distance to TSS:	-137
Nearest PromoterID:	NM_001079559
Entrez ID:	221092
Nearest Unigene:	Hs.657058
Nearest Refseq:	NM_001079559
Nearest Ensembl:	ENSG00000214753
Gene Name:	HNRNPUL2
Gene Alias:	HNRPUL2|SAF-A2
Gene Type:	protein-coding
CpG%:	0.300000
GC%:	0.818182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPUL2 p2@HNRNPUL2 p3@HNRNPUL2 p5@HNRNPUL2 p6@HNRNPUL2 p7@HNRNPUL2 p8@HNRNPUL2 p9@HNRNPUL2
Sample		p1@HNRNPUL2	p2@HNRNPUL2	p3@HNRNPUL2	p5@HNRNPUL2	p6@HNRNPUL2	p7@HNRNPUL2	p8@HNRNPUL2	p9@HNRNPUL2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.32	10.52	3.31	2.34	2.92	0.39	0.00	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.35	11.73	2.83	5.26	3.24	2.02	0.00	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.27	11.19	3.67	2.89	3.67	0.96	0.19	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.69	8.32	3.33	1.46	1.46	1.87	0.00	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.47	9.90	2.25	2.47	4.27	1.57	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.08	10.47	4.07	2.13	4.26	1.94	0.00	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.94	9.80	2.61	2.61	3.92	3.27	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.78	9.69	3.39	3.39	3.88	0.97	0.24	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.18	8.76	2.78	2.99	4.27	2.14	0.21	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	7.54	5.80	4.06	5.22	0.58	0.00	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.77	10.51	5.26	2.83	4.85	0.40	0.81	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	14.64	4.88	2.44	3.25	0.81	0.00	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.77	5.48	0.48	0.16	0.00	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.71	3.31	0.60	0.30	0.00	0.30	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.93	3.95	0.22	0.22	0.00	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.03	4.78	0.25	0.25	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.46	2.40	0.44	0.00	0.22	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.37	3.37	1.69	0.00	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.86	3.20	0.53	0.00	0.00	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	5.72	4.36	0.75	0.00	0.00	0.15	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.15	3.34	0.27	0.27	0.27	0.00	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	4.83	3.97	0.69	0.17	0.17	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.65	4.14	0.65	0.00	0.00	0.26	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.58	1.21	0.24	0.00	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.74	2.06	0.77	0.26	0.00	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	5.06	2.22	0.00	0.00	0.00	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3.85	1.65	1.65	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.31	5.19	0.94	0.24	0.24	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.33	4.20	0.48	0.00	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.60	3.62	0.90	0.18	0.00	0.00	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	3.98	2.72	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	3.32	3.13	0.78	0.00	0.00	0.00	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.59	4.43	0.42	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.10	2.80	0.49	0.16	0.16	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.36	2.62	0.56	0.19	0.00	0.00	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	3.26	4.60	0.38	0.19	0.00	0.19	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.97	3.68	0.82	0.20	0.00	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.65	3.43	0.40	0.00	0.00	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	1.35	0.54	0.00	0.00	0.00	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.20	3.36	0.00	0.00	0.24	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.94	3.06	0.47	0.00	0.24	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.10	4.98	0.59	0.00	0.15	0.29	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.17	2.53	0.42	0.00	0.00	0.00	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.94	3.67	0.52	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.02	1.81	0.80	0.00	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	5.12	3.02	0.93	0.00	0.00	0.23	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.80	2.64	0.72	0.00	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.87	4.17	0.89	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.51	4.55	0.00	0.00	0.00	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	3.24	3.24	0.40	0.00	0.20	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.92	3.28	0.20	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	4.45	2.00	0.00	0.00	0.00	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	41.98	0.00	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.19	2.84	0.35	0.00	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.96	2.98	0.66	0.00	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.03	15.94	2.52	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.05	2.76	0.00	0.46	0.00	0.00	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.51	1.62	0.00	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	3.85	1.93	0.32	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.71	5.97	0.31	0.00	0.31	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	2.12	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.24	2.24	0.00	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	7.17	0.00	0.00	1.59	0.80	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.74	3.74	0.00	0.00	0.00	0.34	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.22	1.30	0.32	0.00	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.97	1.77	0.71	0.00	0.35	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	15.79	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	10.73	4.88	0.49	0.00	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.97	1.98	0.99	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	2.35	0.94	0.00	0.47	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.27	3.64	0.99	0.00	1.32	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.04	1.24	0.00	0.00	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	1.83	0.31	0.00	0.00	0.31	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	7.76	4.59	0.79	0.16	0.00	0.32	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	14.44	9.47	1.28	0.16	0.00	0.64	0.32	1.28
Adipocyte - omental, donor1	11473-119C6	8.65	6.87	0.64	0.25	0.38	0.64	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	11.96	8.22	0.00	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	13.73	9.38	0.33	0.00	0.33	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	15.31	7.02	0.64	0.00	0.00	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	3.30	0.00	1.10	1.10	1.10	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	12.19	0.90	0.90	0.90	0.90	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	16.86	9.21	1.04	0.35	0.17	0.35	0.70	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	31.10	15.25	2.74	0.20	0.59	0.39	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	18.79	9.78	1.54	0.51	0.77	0.26	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	24.25	11.43	2.51	1.12	0.00	0.84	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	14.70	2.94	0.59	0.00	0.00	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	36.92	22.52	2.90	0.88	0.80	0.32	0.80	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	12.59	1.29	0.65	0.65	0.65	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	17.06	7.46	1.07	1.07	0.53	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	27.27	15.02	3.90	0.56	0.56	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	16.64	18.30	1.25	0.83	0.00	0.83	0.83	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	18.59	8.79	0.25	0.50	0.75	0.00	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	15.05	13.09	0.98	0.33	0.65	0.65	0.33	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	19.18	12.48	4.57	0.61	0.91	0.30	1.52	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	20.11	10.61	1.10	0.44	1.10	0.44	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	16.14	7.17	1.08	1.08	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	22.67	12.59	1.08	1.26	3.60	1.98	1.08	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	31.80	6.69	0.00	0.00	3.35	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	24.65	10.68	0.82	0.62	2.05	1.85	0.41	0.62
Anulus Pulposus Cell, donor1	11248-116E6	18.31	16.13	1.14	0.34	0.23	0.23	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	15.92	18.12	1.96	0.49	0.24	0.73	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	10.33	0.90	0.00	0.45	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.16	9.55	0.43	0.00	0.43	0.00	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.55	12.55	1.49	0.30	0.90	0.60	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	15.18	0.00	1.26	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	3.96	0.00	0.66	1.32	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.02	7.47	0.65	0.32	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	10.19	0.97	0.49	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	5.34	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	11.30	0.38	0.38	0.75	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	10.89	0.00	1.45	0.73	0.73	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	2.51	1.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.19	5.77	0.82	0.00	0.16	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	20.47	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.88	2.56	0.30	0.15	0.30	0.15	0.30	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.39	11.25	0.00	0.54	0.00	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.68	12.28	0.38	0.38	0.38	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.42	6.68	1.07	0.53	0.53	0.27	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	9.75	0.98	0.98	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.27	10.28	0.50	0.66	0.00	0.33	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	2.40	1.20	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	12.69	0.51	1.03	0.00	0.34	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.16	11.16	0.97	0.49	0.97	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.90	12.90	0.00	1.14	0.00	0.76	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	6.06	0.00	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.40	14.82	1.14	0.57	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.11	12.19	1.50	0.21	0.86	0.21	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.61	5.68	0.77	0.26	0.52	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.51	8.45	0.94	0.00	0.00	0.47	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.43	9.32	1.29	0.00	0.64	0.32	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	4.28	1.43	0.00	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	8.19	1.17	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.15	8.43	0.30	0.30	0.60	0.60	0.30	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	2.38	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.22	10.17	0.51	0.51	0.00	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.97	12.23	0.25	0.51	0.76	0.51	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	3.18	0.64	0.64	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	8.20	0.43	0.43	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.22	8.26	0.64	0.64	0.42	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.83	4.06	0.58	0.58	0.58	0.29	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	19.84	0.94	0.00	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.04	9.49	0.34	0.00	0.34	0.00	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	14.79	0.00	0.00	2.11	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	7.08	0.43	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	4.81	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	15.31	0.00	1.46	0.00	0.73	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.72	10.34	0.46	0.69	0.46	0.23	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	15.30	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.08	3.81	0.76	0.00	0.25	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.04	9.50	0.83	0.62	1.24	0.41	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.02	5.81	0.00	0.00	0.92	0.31	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.99	13.86	0.00	0.00	0.00	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.97	9.53	0.67	0.22	0.44	0.00	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	1.53	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	14.40	0.00	0.00	0.00	0.55	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.77	10.33	0.53	0.00	0.53	0.00	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.54	4.00	0.36	0.00	1.09	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	24.19	33.04	3.93	3.19	0.61	1.47	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	23.79	23.45	1.71	1.37	0.51	0.51	1.03	0.17
Astrocyte - cerebellum, donor3	11661-122F5	18.04	15.10	1.47	1.05	0.21	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	26.14	20.92	2.44	1.05	0.00	1.39	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	38.02	36.40	3.24	3.40	1.29	0.97	0.65	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	40.27	24.31	1.79	2.09	0.89	0.60	0.75	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	72.37	31.65	2.06	1.72	1.83	0.80	4.70	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	69.91	41.47	2.63	2.76	2.38	1.25	4.26	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	68.16	35.16	2.84	1.37	1.82	1.25	3.76	1.93
Basophils, donor1	12241-129G9	9.68	10.46	1.83	1.83	0.26	0.00	0.00	0.26
Basophils, donor2	12242-129H1	17.68	13.71	1.08	0.36	1.08	0.00	0.00	0.36
Basophils, donor3	12243-129H2	10.73	12.49	1.03	0.29	0.29	0.15	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	20.27	13.58	0.65	0.65	1.94	0.65	0.65	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	15.09	3.66	0.46	0.00	0.46	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	0.00	0.00	7.17	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	8.16	1.26	0.00	0.00	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	21.83	8.32	0.21	0.21	0.00	0.21	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	14.05	8.06	0.69	0.00	0.00	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	21.95	12.96	2.16	0.18	1.62	2.34	1.62	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	45.65	14.84	3.61	2.47	0.72	0.31	0.93	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.48	23.52	4.19	3.26	0.23	0.23	1.16	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	19.19	8.31	1.60	0.64	0.00	0.00	0.32	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	10.34	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.85	10.14	1.69	1.13	0.00	1.69	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	18.75	7.80	0.56	1.48	0.00	0.56	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	20.86	11.20	0.88	1.32	0.22	0.00	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	31.70	15.28	1.42	0.57	0.57	1.70	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.84	14.03	0.38	0.76	0.38	1.14	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	40.44	16.11	1.31	0.66	0.66	0.99	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	11.71	11.42	1.01	0.14	0.43	0.29	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	8.45	7.54	0.91	0.91	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	5.92	8.77	0.47	0.95	0.24	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.36	6.03	0.50	0.17	0.00	0.17	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.86	4.69	0.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.47	3.97	0.25	0.25	0.25	0.00	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.48	3.52	0.20	0.00	0.39	0.20	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.49	3.20	0.53	0.18	0.18	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.74	2.18	0.87	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	3.51	0.23	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	4.22	1.06	0.00	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	2.22	0.00	0.00	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.61	5.80	0.15	0.30	0.45	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.19	6.59	0.20	0.20	0.00	0.20	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.12	6.04	0.42	0.42	0.21	0.21	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.43	4.12	0.00	0.23	0.23	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1.58	4.30	0.68	0.23	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.18	3.93	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.15	8.61	0.27	0.27	0.54	0.81	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.01	6.28	0.00	0.35	0.00	0.17	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	6.73	0.84	0.00	0.00	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.02	3.67	0.37	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.52	2.11	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	3.95	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.96	5.23	0.17	0.35	0.00	0.00	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.09	4.83	0.37	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.02	4.53	0.22	0.00	0.00	0.43	0.43	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.09	6.55	1.64	0.41	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.32	3.01	0.23	0.23	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.93	2.09	0.23	0.00	0.00	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	5.89	2.62	0.00	0.00	0.22	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	8.78	4.62	0.46	0.23	0.69	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	5.85	4.33	0.00	0.22	0.00	0.43	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	8.72	5.92	0.78	0.47	0.31	0.78	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	9.95	5.41	1.05	0.17	0.35	0.52	0.17	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	14.94	10.03	1.34	0.67	0.67	0.67	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	9.44	4.34	0.77	0.51	0.26	0.26	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	6.37	3.73	0.44	0.66	0.44	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	6.53	5.26	0.63	0.00	0.00	0.21	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	20.34	10.17	0.00	2.71	1.36	0.68	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	7.25	1.04	1.04	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	34.65	13.86	0.53	3.73	0.53	0.53	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	8.04	1.07	1.07	0.54	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	7.02	1.40	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	22.75	4.71	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	19.77	10.55	1.32	0.00	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	20.55	15.62	0.82	1.64	0.00	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	22.49	4.35	0.00	1.45	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	17.16	11.61	0.50	1.01	0.50	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	82.83	26.67	7.27	0.40	0.81	2.02	1.21	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	55.53	16.38	5.99	0.00	1.20	2.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	2.01	1.00	0.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	10.11	10.11	1.69	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	22.92	11.65	0.75	1.13	1.13	0.00	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.22	9.70	2.48	0.68	0.23	0.00	0.68	0.23
CD4+ T Cells, donor1	11225-116C1	62.84	25.35	2.14	2.86	0.00	0.36	1.07	1.07
CD4+ T Cells, donor2	11306-117C1	38.58	21.43	0.61	1.22	1.22	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	40.56	22.57	0.30	0.91	0.61	0.00	0.61	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	17.10	5.87	0.00	0.00	0.51	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	21.11	5.84	0.67	0.22	0.67	0.00	0.45	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	30.18	6.61	0.86	0.00	0.00	0.00	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	16.59	6.64	0.47	0.47	0.95	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	15.45	7.02	0.00	0.70	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	3.30	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	13.15	8.96	1.01	0.14	0.29	0.00	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.86	8.98	0.85	0.51	0.34	0.00	0.17	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.11	8.87	0.32	0.32	0.48	0.16	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.10	4.48	1.34	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	16.42	6.64	1.40	0.35	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.52	11.00	1.32	0.44	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	20.24	9.28	0.42	0.42	0.42	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	33.87	9.35	0.42	0.62	0.42	0.00	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.72	6.68	1.00	0.33	0.33	0.00	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	20.94	5.98	0.00	0.27	0.27	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	15.54	9.65	0.54	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	14.35	0.00	1.79	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	27.63	10.38	0.93	1.11	0.74	0.19	0.00	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.45	6.93	0.87	0.87	0.00	0.22	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	23.54	8.62	0.84	0.63	0.63	0.42	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	11.12	9.61	0.00	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.00	9.96	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.61	10.90	0.00	0.00	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.61	19.30	0.00	0.99	0.49	0.99	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	21.23	15.69	0.92	0.00	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	30.71	9.77	1.40	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	44.03	20.49	1.38	1.38	0.55	0.55	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	51.53	19.88	1.47	0.98	0.74	0.00	0.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	20.02	1.54	0.00	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	41.18	17.55	0.72	0.36	1.07	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	31.85	19.39	1.38	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	48.13	13.42	0.00	0.33	0.65	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	43.93	15.39	1.88	1.13	1.50	0.75	1.88	0.00
CD8+ T Cells, donor3	11383-118B6	47.72	18.68	1.01	1.26	0.50	0.25	0.25	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	14.45	8.26	1.15	0.46	1.15	0.69	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.74	6.47	0.00	0.24	0.24	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.85	4.92	1.09	0.27	0.00	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.41	4.20	0.00	0.30	0.30	0.00	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.24	4.56	0.00	0.00	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.42	4.55	0.00	0.68	0.45	0.23	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.78	9.78	0.43	0.43	0.43	0.65	0.22	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	14.48	5.79	0.00	0.26	0.00	0.00	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.24	7.04	0.70	0.23	0.23	0.70	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.30	9.96	0.91	0.60	0.60	0.60	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	19.75	9.01	1.16	0.00	1.45	0.00	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	14.39	8.26	0.53	0.27	0.27	0.00	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.14	14.01	1.31	0.00	0.88	0.88	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.21	12.30	0.46	0.46	0.00	0.00	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	13.43	0.75	0.00	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.57	4.32	1.08	0.72	1.08	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.84	7.48	0.00	0.29	0.00	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	13.67	5.19	0.71	0.24	0.47	0.00	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.16	10.14	0.00	0.00	0.32	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.22	8.61	1.54	0.00	0.62	0.31	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.39	8.98	0.64	0.00	0.00	0.32	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	14.92	10.71	0.76	1.15	1.53	1.53	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.52	11.82	0.79	0.00	0.39	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.15	8.32	0.00	0.00	1.51	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	16.06	1.61	0.00	0.80	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.09	20.98	0.00	0.70	0.00	0.00	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	23.04	2.00	1.00	0.00	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	63.97	21.93	5.48	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	15.32	9.39	1.98	0.00	0.49	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	17.57	11.79	0.74	0.42	0.21	0.21	0.74	0.00
Chondrocyte - de diff, donor1	11261-116G1	23.23	12.83	2.43	0.69	0.69	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	12.79	6.40	0.00	0.00	0.00	0.36	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	19.57	8.42	1.37	0.57	0.34	0.00	0.68	0.00
Chondrocyte - re diff, donor2	11339-117F7	8.06	13.43	0.90	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.18	16.58	2.43	0.40	0.00	0.00	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	21.46	30.64	3.44	2.18	0.80	0.80	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	16.67	17.32	1.50	1.71	1.07	0.21	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	20.18	19.91	1.86	1.50	0.44	0.35	0.88	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	40.72	34.48	6.05	1.93	0.92	1.28	0.83	0.28
Corneal Epithelial Cells, donor1	11526-119I5	15.59	7.90	1.10	0.22	1.54	0.88	0.00	0.66
Corneal Epithelial Cells, donor2	11606-120I4	20.48	12.51	1.14	0.00	4.55	1.14	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	20.71	10.23	1.79	1.02	1.79	2.05	0.00	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.89	35.66	3.30	2.48	1.82	1.16	0.00	2.48
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.35	36.90	2.84	1.58	1.58	1.89	0.32	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	27.61	0.00	6.90	0.00	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.01	31.10	1.51	0.97	2.27	1.40	0.22	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	22.21	13.32	0.34	1.37	0.00	0.68	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.10	10.45	0.65	0.65	0.00	0.65	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.94	11.61	0.48	0.48	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	18.84	8.00	0.50	0.50	0.33	0.33	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	10.56	1.17	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	23.47	12.44	1.13	0.57	1.13	0.00	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	23.59	8.26	1.18	0.00	0.00	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	24.43	9.02	1.75	0.58	0.58	0.00	0.87	1.16
Endothelial Cells - Artery, donor2	11341-117F9	25.88	15.29	0.94	0.94	1.18	0.47	0.47	0.71
Endothelial Cells - Artery, donor3	11413-118E9	19.11	8.77	1.40	1.05	1.23	0.53	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.85	9.97	0.89	0.66	0.00	0.22	0.44	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	19.47	10.35	1.83	0.30	0.61	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.32	10.71	0.85	0.56	0.28	0.28	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	13.67	8.32	0.30	0.00	0.30	0.30	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	7.29	3.64	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	22.54	8.37	0.99	0.14	0.14	0.14	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	35.61	19.61	0.40	1.20	1.20	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	17.30	13.10	1.05	0.00	2.10	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.21	15.41	2.48	1.24	1.12	1.24	0.50	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	57.79	20.21	1.74	1.30	1.74	1.30	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	61.80	22.47	3.05	1.95	0.98	0.73	1.59	0.49
Endothelial Cells - Vein, donor1	11267-116G7	20.48	9.10	0.00	2.28	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	19.56	6.99	0.00	1.40	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.39	10.05	0.94	0.79	0.47	0.16	0.79	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	28.05	3.30	1.65	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	3.57	0.00	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.10	12.46	1.95	1.22	0.00	0.73	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	12.48	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.01	8.21	1.23	0.00	0.82	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.71	2.85	0.44	0.00	0.33	0.00	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.73	4.01	0.76	0.43	0.33	0.33	0.54	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.04	12.73	1.21	0.73	0.36	0.12	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.24	14.19	1.23	0.68	0.41	0.41	0.55	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.13	10.13	0.74	0.21	0.42	0.53	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	12.38	1.05	0.53	0.79	0.26	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.89	17.94	1.33	0.33	0.66	0.66	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	14.52	9.98	0.91	0.45	0.45	0.00	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	15.92	0.00	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.45	10.72	0.63	0.63	0.47	0.32	0.63	0.16
Fibroblast - Cardiac, donor4	11452-119A3	25.46	15.46	0.00	0.91	0.61	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	29.70	11.04	1.40	0.76	0.25	0.00	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	30.77	11.22	1.21	1.06	0.91	0.30	0.45	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.02	26.40	1.21	2.81	0.40	0.54	0.27	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.10	22.00	1.29	0.43	0.86	0.43	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	10.25	1.46	0.00	0.00	1.46	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	35.75	18.68	2.54	1.61	0.00	0.00	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	21.03	14.59	1.02	0.68	0.00	0.68	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	19.02	12.91	1.41	0.47	0.94	0.70	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	17.45	15.57	2.36	2.36	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	17.77	12.09	1.09	0.48	0.36	0.24	0.97	0.36
Fibroblast - Dermal, donor4	11450-119A1	39.79	15.71	1.81	1.36	0.79	1.02	0.79	0.11
Fibroblast - Dermal, donor5	11454-119A5	38.55	12.39	0.87	0.87	0.70	0.17	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	47.75	19.49	1.46	2.44	0.65	2.76	0.32	0.49
Fibroblast - Gingival, donor1	11237-116D4	20.61	13.12	1.46	0.21	0.62	1.04	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	25.15	12.05	1.83	1.31	0.52	0.26	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	37.03	13.57	1.32	1.05	1.98	1.32	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	25.53	15.95	2.42	0.48	0.19	0.19	0.87	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	12.47	2.08	0.00	0.00	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.56	9.16	0.18	0.00	1.06	0.53	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.79	17.77	2.18	1.09	0.47	1.09	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.50	18.26	1.49	0.41	0.68	1.08	0.41	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.00	13.41	1.76	0.00	0.35	0.71	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.55	13.31	1.75	0.73	0.44	0.73	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.77	15.68	2.18	1.09	0.27	0.95	0.27	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	34.66	14.26	1.97	1.21	1.86	1.10	0.33	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.59	11.89	2.35	0.15	0.29	0.15	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	8.16	2.72	2.72	0.00	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	35.81	19.40	1.49	1.49	0.00	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	37.14	15.83	1.90	0.63	0.42	0.63	1.27	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	39.15	29.16	2.50	3.33	1.67	1.67	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	12.59	0.00	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.72	3.64	0.84	0.00	0.28	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	44.25	25.58	3.65	2.44	1.62	2.44	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	11.98	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	23.83	0.00	0.00	0.00	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.44	12.41	2.91	0.97	1.16	1.16	0.97	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	59.16	23.21	1.21	0.61	1.37	1.52	1.67	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.87	19.28	1.84	0.61	1.53	0.31	0.92	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.20	17.94	3.05	0.76	0.38	0.38	2.29	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	11.61	2.43	0.27	0.27	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.85	11.02	1.28	0.12	0.81	0.58	0.58	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.76	9.17	0.77	0.33	0.33	0.55	0.33	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.14	18.69	2.24	2.24	0.41	1.42	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	13.36	1.34	2.00	2.00	0.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	12.65	0.00	0.00	0.40	0.40	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	40.48	18.46	2.18	1.19	1.79	1.39	0.99	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.74	8.70	0.18	0.00	0.18	0.00	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.40	12.42	1.38	0.59	0.00	0.20	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	26.48	17.75	2.11	0.60	1.50	0.00	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.45	22.45	1.94	0.86	0.22	0.76	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.83	20.25	1.77	0.51	0.76	0.51	0.76	0.76
Fibroblast - skin normal, donor1	11553-120C5	13.95	13.78	1.80	0.16	0.49	0.16	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.66	19.25	1.60	0.20	0.20	1.00	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	18.89	17.78	1.21	1.11	0.40	0.20	0.50	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	40.20	32.64	1.51	0.60	1.51	0.60	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.40	10.27	1.08	0.25	0.25	0.25	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.15	13.51	0.51	0.34	0.34	0.34	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.65	15.11	0.33	2.63	1.31	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.92	19.60	2.56	0.75	0.32	0.64	0.21	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	22.60	15.18	1.69	1.18	0.51	1.01	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.76	11.45	0.63	0.47	0.47	0.31	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	265.92	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	17.43	0.87	0.87	2.61	3.49	0.00	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.09	10.40	1.04	0.52	1.39	0.35	0.87	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.19	11.45	0.26	1.04	0.26	1.04	1.30	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.29	9.20	0.77	0.26	1.53	0.51	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	15.31	5.36	2.30	1.53	1.53	3.06	0.77	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.04	6.38	1.28	1.28	8.29	2.55	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	33.38	11.41	2.28	2.85	4.28	6.56	0.29	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.57	16.82	1.38	1.65	1.93	2.76	1.10	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.18	18.49	2.51	0.91	1.83	1.14	0.91	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	32.69	7.93	1.19	1.59	2.58	3.37	0.79	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	30.93	11.90	3.17	0.79	1.59	1.59	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	20.22	14.02	0.33	1.30	1.63	1.30	0.33	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.19	7.08	2.65	1.33	4.86	6.19	3.10	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	44.80	16.96	2.69	1.84	2.40	2.69	1.41	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	40.64	19.58	2.59	1.85	2.59	2.09	1.23	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.40	14.77	1.88	0.54	2.42	2.69	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.56	12.64	0.99	0.50	0.62	2.35	0.12	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.94	13.57	0.97	1.11	1.25	1.25	1.52	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	23.58	8.95	1.42	1.02	1.22	1.83	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.89	11.41	0.91	0.46	0.91	1.14	0.46	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.99	16.19	1.12	0.50	1.74	1.49	1.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	32.13	11.58	1.31	0.00	0.66	1.97	1.53	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.21	10.64	2.07	1.48	2.07	1.18	1.77	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.83	18.44	1.91	0.95	0.79	1.11	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.03	12.73	0.89	0.45	0.67	0.89	1.56	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	41.33	15.32	1.61	1.21	1.01	1.01	0.60	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.82	19.34	2.71	2.04	2.37	1.36	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.99	13.66	1.68	0.98	2.13	1.86	0.44	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.61	8.95	2.19	0.10	1.04	1.77	0.00	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.78	6.32	2.39	0.17	1.20	0.51	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	45.81	21.80	1.44	1.44	1.44	1.55	1.33	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.12	12.98	2.08	0.50	1.58	1.58	0.58	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.11	13.88	2.45	1.02	1.63	1.84	0.20	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.61	12.38	2.48	0.83	1.44	1.24	1.65	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	44.16	21.33	2.19	1.38	2.54	1.38	0.92	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.85	15.84	1.83	1.83	2.00	1.33	1.50	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.89	15.65	1.98	1.32	1.32	2.20	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	41.94	20.17	2.46	1.23	1.48	1.60	1.23	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.45	16.05	2.59	1.13	1.95	2.27	1.95	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	28.54	16.36	2.25	0.32	1.28	0.96	1.28	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.47	23.59	1.80	0.85	2.37	1.90	0.85	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.26	16.77	1.90	0.63	1.42	0.79	1.11	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.06	14.90	3.34	1.22	2.74	0.91	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	36.80	22.68	1.99	1.25	2.09	1.36	1.25	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	26.13	16.25	2.42	0.22	1.32	1.10	0.66	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.02	13.75	3.65	0.56	1.68	0.84	1.40	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.22	18.52	2.31	1.02	2.87	1.11	0.37	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.32	12.03	2.41	0.27	1.07	1.34	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.91	16.98	1.99	0.46	2.14	1.22	1.22	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.76	20.73	1.81	1.30	2.07	0.91	0.00	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.00	18.98	2.98	0.27	0.00	2.17	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	29.86	21.02	2.58	0.18	2.40	1.11	0.37	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.49	15.13	1.75	0.44	1.75	1.54	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	44.63	41.65	7.93	0.00	0.00	0.00	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.88	15.96	1.71	0.53	1.85	0.26	0.66	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.60	14.32	2.62	1.01	1.41	1.21	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	24.15	17.28	3.05	1.27	0.76	0.76	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	34.24	11.15	1.19	2.19	3.18	4.58	1.19	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.46	14.95	1.69	1.23	2.16	2.77	1.54	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	55.65	15.34	2.45	4.09	4.50	2.05	1.43	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.58	3.44	0.63	0.63	2.19	1.88	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	12.71	4.52	1.41	1.98	1.98	2.83	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	25.83	15.68	1.38	2.77	3.69	2.31	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	12.37	2.47	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	19.73	17.41	1.16	1.93	2.71	1.55	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	6.42	1.60	0.00	4.81	6.42	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	17.39	0.00	5.22	3.48	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	16.92	9.44	2.28	1.95	1.63	2.28	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.47	18.12	1.65	3.29	2.47	2.88	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	10.00	6.66	3.33	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.62	11.75	1.68	2.24	2.24	1.40	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	26.80	11.44	0.00	2.29	3.60	1.63	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	11.74	1.68	0.00	0.84	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	35.31	12.72	3.82	3.18	3.18	2.23	0.00	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.15	10.19	1.36	1.02	1.02	1.36	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	2.09	0.00	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	42.38	14.89	0.57	0.00	2.86	3.44	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.16	6.81	2.37	0.89	1.48	2.07	0.59	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	13.55	0.00	0.00	3.39	3.39	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.07	17.40	1.24	3.31	1.66	0.41	2.07	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	37.74	14.27	2.30	1.84	2.30	2.99	0.92	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	10.54	0.00	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.22	8.46	3.46	0.77	1.54	1.92	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.38	7.50	2.28	1.96	1.63	2.28	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.07	5.35	4.01	0.00	0.67	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	39.68	10.40	3.08	0.00	1.93	1.93	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.29	16.09	2.74	1.71	2.74	1.71	1.71	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	9.94	14.91	0.00	2.48	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	43.41	8.02	2.36	0.94	0.00	2.83	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	10.86	1.81	1.21	3.02	0.60	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.57	9.66	3.05	0.51	2.03	3.05	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	37.89	10.77	1.60	0.40	1.99	3.99	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.57	7.89	2.96	0.49	2.96	2.47	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	7.08	4.72	0.00	0.00	4.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.59	10.50	0.00	0.00	1.75	3.50	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.04	11.41	1.32	0.44	0.44	1.32	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	32.21	9.32	0.85	0.00	3.39	2.54	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.26	7.16	2.39	1.19	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	8.73	2.43	0.49	1.94	1.46	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	7.99	1.14	2.28	0.00	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.39	20.38	0.42	1.25	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	7.87	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.49	12.37	2.22	0.32	0.95	0.32	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.44	10.03	1.25	0.42	0.42	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.19	16.59	1.16	2.20	3.48	2.67	0.46	4.06
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.28	13.50	1.01	1.86	3.54	2.36	0.51	2.87
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.97	15.24	1.82	2.28	4.32	1.37	0.23	3.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.16	15.30	0.77	1.97	2.95	1.97	0.87	2.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	22.14	13.97	0.86	2.79	3.44	2.15	0.00	1.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	19.16	15.72	0.43	1.94	3.66	1.72	0.43	3.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	14.07	12.20	0.62	1.00	2.24	1.74	0.37	2.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	13.21	10.29	1.20	1.37	2.23	2.06	0.00	2.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	9.61	0.64	2.88	2.56	0.32	0.32	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.14	10.07	2.24	1.68	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.07	9.09	0.43	1.30	0.87	0.87	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	2.64	0.00	0.00	0.00	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.16	13.76	2.82	0.71	0.71	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.15	9.44	1.45	0.00	0.73	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.55	12.76	0.87	0.35	1.57	0.70	0.17	0.52
Hepatocyte, donor1	11523-119I2	32.69	7.26	0.00	0.00	1.21	0.00	1.21	1.21
Hepatocyte, donor2	11603-120I1	26.93	17.24	1.08	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	36.20	12.88	1.23	1.23	0.61	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	43.73	14.36	1.96	3.26	2.61	0.00	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	41.95	25.52	0.87	3.50	2.62	3.32	0.35	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.88	16.46	0.69	0.96	0.82	0.41	0.96	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	0.00	6.37	6.37	3.18	0.00	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	33.23	11.08	2.77	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	5.01	0.00	0.00	2.50	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	23.74	0.00	0.00	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	10.25	2.56	0.00	0.00	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	14.62	0.00	6.50	0.00	3.25	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	8.34	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	48.97	10.59	0.00	1.32	1.32	1.32	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	7.76	1.11	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	32.75	10.08	1.26	1.26	0.00	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	34.03	3.09	0.00	4.64	0.00	0.00	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	10.34	0.65	0.65	3.88	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	9.66	3.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	12.22	2.44	0.00	3.26	1.63	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.67	8.40	1.68	0.84	0.42	1.26	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	44.20	15.27	0.80	0.80	2.41	0.00	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	8.31	1.85	0.92	0.00	0.92	2.77	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	24.07	7.55	0.94	0.47	0.47	1.89	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	10.88	3.63	0.00	0.91	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	9.69	1.08	1.08	0.00	1.08	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	15.25	0.00	0.00	2.54	1.27	2.54	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	0.00	0.00	0.00	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	38.26	16.58	1.28	1.28	0.64	1.28	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	14.58	3.65	9.11	1.82	0.00	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	45.70	15.00	1.43	0.71	1.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	13.27	3.32	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.93	12.96	0.62	2.47	1.23	0.31	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	49.17	12.29	0.00	0.00	0.00	5.27	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	18.86	0.00	3.14	0.00	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.20	6.26	1.39	2.78	2.09	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	13.28	0.00	2.21	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	19.45	0.00	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.90	4.36	0.00	0.87	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	6.75	0.00	2.25	0.00	4.50	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	30.94	5.33	2.13	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	8.31	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	48.44	8.55	0.00	0.00	0.00	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	28.53	10.12	1.84	1.84	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	6.34	1.06	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	18.77	11.10	2.37	0.57	2.28	2.04	0.08	2.04
Keratinocyte - epidermal, donor2	11349-117G8	5.27	2.93	0.00	1.17	2.34	0.59	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	28.02	14.10	1.80	0.85	1.89	1.89	0.85	1.99
Keratinocyte - oral, donor1	11251-116E9	29.74	18.50	2.61	0.34	1.36	2.04	0.68	1.14
Keratocytes, donor1	11527-119I6	20.29	16.85	1.38	0.34	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	31.64	10.55	2.34	1.17	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	31.22	9.09	1.58	0.59	0.40	0.40	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	81.32	39.56	4.40	0.00	0.00	2.20	17.58	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	11.87	1.08	1.08	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.18	28.37	0.46	1.85	0.46	0.81	0.81	0.23
Lens Epithelial Cells, donor3	11690-122I7	20.38	20.99	0.91	0.71	1.11	0.71	1.01	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.60	8.06	1.19	0.12	0.71	0.12	0.47	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.84	5.02	1.12	0.00	0.00	0.00	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.41	8.50	1.26	1.10	0.31	0.00	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	11.29	0.00	0.54	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.39	4.73	1.26	0.32	0.95	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.28	5.18	1.08	0.32	0.32	0.22	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.59	6.16	0.41	1.23	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.64	5.31	0.25	0.25	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.16	6.90	0.84	0.00	0.56	0.28	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	7.12	0.40	0.79	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.29	6.59	1.55	0.39	0.00	0.00	0.00	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.55	5.18	0.56	0.37	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.94	3.83	0.70	0.35	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.60	4.53	0.72	0.00	0.95	0.48	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.62	6.18	0.82	0.27	0.27	0.27	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	9.85	1.54	0.31	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	5.30	0.62	0.31	0.00	0.00	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.95	6.04	0.91	0.18	0.37	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.15	5.27	0.99	0.33	0.33	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	2.64	0.59	0.59	0.00	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.18	5.48	0.00	0.50	0.25	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	17.94	3.88	0.48	0.00	1.45	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.27	4.04	0.81	0.00	0.00	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.65	8.33	0.45	0.45	0.30	0.45	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.41	6.74	1.56	0.52	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.70	6.49	0.21	0.00	0.21	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.04	7.07	0.60	0.30	0.45	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	6.19	0.00	0.00	0.00	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.11	6.77	0.00	0.19	0.00	0.38	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	15.27	6.89	0.53	0.32	0.42	0.32	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	8.72	0.97	0.97	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.22	5.95	0.99	0.33	0.66	0.33	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.22	6.81	0.25	0.74	0.25	0.00	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.92	11.11	1.85	1.11	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.13	4.45	0.00	0.25	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.61	5.91	0.96	0.55	0.27	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.30	6.11	0.32	0.32	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.22	7.00	0.61	0.91	0.30	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.08	7.28	0.70	0.70	0.42	0.14	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.00	7.82	1.07	0.36	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	2.91	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.16	6.07	0.93	0.62	0.47	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.32	6.80	0.00	0.00	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.39	7.19	0.98	0.33	0.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.42	8.24	0.94	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.66	6.68	0.87	0.50	0.50	0.37	0.87	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.25	5.38	1.54	0.51	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.30	5.67	0.60	0.90	0.00	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	9.06	2.27	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	16.11	0.77	0.77	0.77	2.30	3.84	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	19.30	0.74	2.97	0.00	3.71	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.08	9.73	0.42	2.54	2.96	2.54	0.42	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	5.63	1.41	2.11	2.81	3.52	0.00	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	11.21	0.00	0.00	0.93	4.67	0.93	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	7.73	0.52	0.52	3.61	2.06	0.52	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	4.76	2.38	0.00	0.00	1.19	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.12	5.88	0.45	1.13	2.26	1.58	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.58	11.63	0.87	2.04	2.62	1.45	1.16	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.96	16.66	0.00	1.35	2.25	1.80	0.45	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.04	9.48	0.68	1.35	2.30	2.57	0.27	2.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	18.49	9.76	0.51	0.51	3.59	2.05	0.00	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.88	16.94	1.41	2.47	2.82	2.47	0.35	3.18
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	9.99	0.67	1.33	2.00	3.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.81	7.64	0.00	0.51	3.57	1.02	0.51	4.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.01	12.01	1.07	3.20	3.20	2.93	0.53	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.83	22.11	0.38	1.51	2.65	1.32	0.76	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	7.98	0.61	2.45	4.29	4.91	1.23	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	12.23	0.82	0.00	2.45	2.45	1.63	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	20.82	19.37	1.04	1.04	3.33	2.29	0.83	5.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.02	13.45	1.40	1.12	5.04	1.96	0.56	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	20.61	2.06	4.12	1.03	4.12	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	28.74	16.55	1.45	2.32	1.74	1.16	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.45	11.36	1.20	0.60	3.29	3.89	0.30	4.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.11	23.79	2.21	3.32	3.32	2.21	0.55	4.43
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.27	19.09	0.71	0.35	3.53	1.41	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.23	9.96	0.37	0.37	2.58	2.58	0.37	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	11.51	0.00	2.30	2.30	2.30	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.27	18.42	1.15	0.77	4.22	2.69	0.77	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	9.62	0.57	0.00	3.40	1.13	0.00	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	13.13	0.00	2.46	1.64	1.64	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	22.14	12.20	0.45	2.26	3.16	1.36	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	16.52	10.77	0.72	0.72	0.72	2.15	0.00	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	15.68	0.75	1.49	2.99	0.75	0.75	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.81	13.38	1.11	1.86	3.72	2.23	0.37	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	15.51	12.49	0.43	0.00	1.72	3.02	0.43	3.45
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	22.26	24.83	0.86	3.43	0.86	1.71	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.66	24.32	1.00	1.67	3.66	3.00	1.33	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.69	10.26	1.21	0.60	3.02	1.81	0.00	4.83
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	12.09	0.71	2.13	2.13	3.55	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.94	14.44	0.69	0.34	3.09	1.37	1.03	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.64	15.03	1.61	0.54	2.68	1.61	0.54	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	15.49	0.67	2.02	1.35	1.35	0.67	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.89	15.56	0.37	0.74	4.82	2.96	0.37	4.07
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	8.14	2.33	1.16	0.00	3.49	0.00	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	25.39	7.40	1.06	0.00	4.23	3.17	0.00	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.01	25.21	0.40	1.20	1.60	1.20	0.40	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.99	7.27	1.45	0.00	1.45	1.45	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	18.40	13.03	0.77	0.77	1.53	4.60	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	13.32	0.49	0.49	3.45	1.48	0.49	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	3.76	0.94	0.00	3.76	2.82	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	9.05	1.01	2.51	0.50	1.01	0.00	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.22	11.27	0.00	0.90	3.60	3.15	1.35	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	12.05	3.44	1.72	0.00	0.00	0.00	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	23.16	11.13	0.45	1.34	3.12	2.67	2.23	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	20.72	12.51	0.78	3.13	3.13	3.52	1.17	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	22.43	9.24	1.98	0.00	0.66	2.64	0.66	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.64	11.94	0.52	2.08	0.52	2.59	1.56	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	21.88	19.69	2.19	3.06	3.06	2.19	0.88	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	10.06	1.12	0.00	1.68	1.12	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	19.43	11.92	0.88	1.32	1.77	1.32	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	12.34	0.00	1.93	0.77	1.54	1.54	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	9.62	1.01	0.51	5.06	2.53	0.00	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.94	17.30	0.00	0.96	1.44	1.92	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.27	15.50	0.40	1.59	3.58	1.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	6.68	0.61	0.00	1.22	2.43	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	11.07	0.00	2.08	2.08	0.69	0.69	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.04	15.58	0.00	1.52	4.18	0.38	0.00	3.80
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.36	9.30	0.00	1.55	3.10	3.10	0.00	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.12	13.30	0.60	1.81	2.42	3.02	0.00	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.65	16.16	1.90	1.27	3.80	0.63	0.32	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	6.93	0.53	0.00	5.86	2.13	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	4.60	1.72	1.72	2.30	1.15	0.00	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	15.94	0.51	1.54	4.63	1.54	1.03	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.22	6.37	0.00	0.71	2.83	2.12	0.00	3.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.75	12.48	0.00	0.57	3.97	0.57	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.55	13.73	1.25	0.42	3.74	1.66	0.83	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	7.83	0.00	3.13	2.35	2.35	0.00	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.03	13.78	0.42	1.25	1.67	3.34	0.00	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.44	13.94	0.46	0.46	2.79	1.86	0.93	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	8.70	0.67	0.67	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.25	14.97	1.07	2.14	1.60	1.60	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.16	18.59	0.40	4.04	2.02	1.21	0.81	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	8.26	0.00	0.92	2.75	2.75	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	7.11	0.00	0.00	1.78	1.78	0.00	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	21.09	11.97	1.71	1.71	1.71	2.28	0.57	3.42
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.80	7.67	0.77	1.53	1.53	2.30	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.23	14.23	2.19	0.55	4.38	3.28	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	15.59	12.92	0.89	0.45	2.23	0.89	0.45	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.96	10.66	1.04	0.52	1.56	1.04	0.00	2.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	16.58	7.96	0.66	0.66	1.33	1.33	0.00	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	12.47	0.00	0.00	6.24	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	25.53	16.18	1.14	1.14	1.14	1.37	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	7.52	11.74	0.55	0.37	0.37	0.73	0.55	0.55
Macrophage - monocyte derived, donor3	11389-118C3	21.89	17.70	0.79	1.05	1.57	1.18	0.39	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.19	6.90	1.06	1.06	0.00	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	12.68	11.41	1.43	0.32	0.95	0.32	0.48	0.48
Mallassez-derived cells, donor3	11930-125I4	14.73	10.98	2.08	0.56	0.97	0.97	0.28	0.56
Mammary Epithelial Cell, donor1	11273-116H4	29.89	22.12	3.09	1.00	1.49	0.80	0.50	0.60
Mammary Epithelial Cell, donor2	11350-117G9	25.77	19.11	2.61	1.74	2.32	1.74	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.70	11.47	1.00	1.00	0.75	0.00	0.00	1.00
Mast cell - stimulated, donor1	11487-119E2	25.76	30.51	2.71	2.03	0.00	1.36	0.00	0.68
Mast cell, donor1	11563-120D6	56.02	27.79	3.46	0.97	1.95	0.97	1.95	0.43
Mast cell, donor2	11565-120D8	98.96	38.34	1.78	1.49	1.49	0.30	2.97	0.59
Mast cell, donor3	11566-120D9	115.26	36.47	2.03	2.48	0.45	1.80	2.93	1.13
Mast cell, donor4	11567-120E1	103.00	37.41	3.55	1.24	0.71	0.89	3.01	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	44.14	23.95	2.00	0.33	1.22	1.33	0.78	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	39.11	16.34	2.92	1.17	2.33	2.33	0.58	4.09
Mast cell, expanded, donor5	11939-126A4	41.07	12.73	0.92	1.03	1.03	1.03	0.23	0.80
Mast cell, expanded, donor8	11941-126A6	63.93	23.60	4.52	1.84	1.34	1.00	1.17	1.67
Melanocyte - dark, donor1	11502-119F8	30.45	7.16	0.50	0.70	0.20	0.30	0.90	0.00
Melanocyte - dark, donor2	11582-120F7	19.03	11.07	3.11	0.69	0.69	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	24.92	25.28	3.19	1.16	2.54	2.32	0.65	1.81
Melanocyte - light, donor1	11274-116H5	11.75	11.99	1.88	0.24	1.18	1.18	0.24	1.41
Melanocyte - light, donor2	11351-117H1	9.55	7.51	2.05	1.36	0.68	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	10.41	6.07	2.60	1.73	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	27.80	15.93	0.73	1.56	2.39	1.46	0.62	1.46
Melanocyte, donor2 (MC+2)	12739-135I3	19.36	19.90	2.42	0.27	2.69	2.42	0.54	2.42
Melanocyte, donor3 (MC+3)	12837-137B2	26.25	22.50	2.14	1.87	4.82	2.41	0.54	4.29
Meningeal Cells, donor1	11493-119E8	27.29	45.90	2.73	6.33	0.87	1.24	0.37	0.62
Meningeal Cells, donor2	11573-120E7	16.29	34.33	1.76	5.72	1.32	1.32	0.88	0.44
Meningeal Cells, donor3	11654-122E7	20.95	22.66	2.53	2.77	1.87	0.82	0.08	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	30.80	16.54	2.00	0.86	2.00	1.71	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.74	5.43	0.50	0.10	0.30	0.40	0.10	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	11.83	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	23.55	7.85	5.23	0.00	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.09	10.05	1.44	0.00	0.72	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.61	10.16	1.27	0.21	0.85	0.21	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.56	8.04	0.50	0.50	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.49	18.46	2.42	0.66	0.66	1.76	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	25.57	15.34	2.19	1.46	2.19	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	28.24	14.73	1.43	0.61	1.64	1.02	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.70	13.99	1.11	0.14	0.14	0.55	0.55	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.50	7.06	1.12	0.37	0.00	0.74	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.58	10.13	2.50	0.39	0.00	0.39	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	7.72	0.59	0.30	0.59	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	4.67	2.34	0.00	0.00	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.74	10.89	0.64	0.64	2.56	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.13	13.47	1.06	0.71	1.06	0.71	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	26.89	11.57	1.56	0.00	0.00	0.00	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	27.58	13.79	1.45	0.00	1.45	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	12.73	6.10	0.27	0.53	1.06	0.27	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	8.51	5.00	1.50	0.00	0.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	15.32	9.47	0.36	0.43	0.36	0.51	0.65	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	51.31	108.03	5.40	4.05	2.70	6.75	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.49	17.73	1.97	0.25	0.49	0.74	0.99	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.72	22.67	0.88	0.88	1.47	1.47	0.00	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	31.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	12.40	0.62	0.31	0.31	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.09	14.94	0.83	0.00	0.83	1.66	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	55.59	2.32	0.00	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.27	13.76	0.25	0.50	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	16.29	1.86	0.00	1.86	2.79	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	97.33	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	16.87	16.87	0.61	0.20	0.61	0.81	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.52	14.25	0.79	0.79	0.79	1.98	0.40	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	85.51	8.55	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	7.96	0.88	0.00	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	12.92	0.00	0.00	1.52	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	25.00	31.58	1.32	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.95	11.46	0.42	0.00	1.06	0.85	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	16.57	0.92	0.00	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	10.73	0.89	0.00	1.19	0.60	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	43.59	0.00	3.35	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	169.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.03	9.53	0.75	0.00	0.50	0.00	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.83	15.21	0.48	0.24	0.24	1.66	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	27.09	0.00	1.11	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.06	6.45	0.92	0.46	0.23	0.69	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.00	7.78	0.84	0.21	0.63	0.84	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.13	8.15	0.41	0.00	0.20	0.41	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.51	7.29	0.21	0.21	0.21	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.23	17.34	0.67	0.22	0.67	1.11	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	72.23	103.18	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.54	8.10	0.44	0.00	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	16.73	0.51	0.00	0.51	1.52	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	41.42	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	11.14	0.27	0.00	0.00	0.54	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.35	14.12	0.00	0.00	0.29	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	34.89	1.09	0.00	1.09	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	5.29	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.00	10.81	0.40	0.40	1.20	0.40	0.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	43.88	5.48	1.37	1.37	2.74	0.00	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	5.51	0.00	0.00	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	44.85	2.04	2.04	2.04	0.00	0.00	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.76	8.76	0.44	0.00	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	45.25	2.21	0.00	1.10	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	25.62	52.51	0.64	1.28	2.56	1.92	0.00	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.16	8.93	0.99	0.00	0.50	0.25	0.74	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	24.36	1.39	0.70	0.00	0.00	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	81.77	2.21	2.21	2.21	0.00	0.00	6.63
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.33	10.60	1.37	1.03	0.34	1.37	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	22.32	1.31	1.31	0.88	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.93	46.87	1.42	0.36	2.13	0.71	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.70	11.22	0.00	0.84	0.84	0.84	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	15.79	1.25	0.42	0.42	2.08	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	48.95	1.17	0.00	1.75	0.00	1.75	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	14.18	1.81	0.00	0.90	0.30	0.00	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.84	15.86	0.42	0.00	1.25	0.42	0.00	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	86.63	7.22	0.00	7.22	7.22	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	11.08	0.00	0.92	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	25.61	0.57	0.57	2.28	2.85	1.14	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.60	26.25	1.66	0.41	1.66	0.97	0.00	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.07	12.18	0.52	0.52	0.52	0.26	0.00	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.73	23.16	1.72	0.86	0.86	1.72	0.86	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.23	42.56	1.27	0.00	4.45	0.64	1.27	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.94	12.81	1.07	0.27	0.80	1.07	0.00	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.37	18.86	0.90	0.00	2.10	1.20	0.30	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.93	19.21	1.13	0.00	0.71	0.28	0.57	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.87	8.92	0.32	0.00	0.32	0.96	0.00	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.91	23.00	1.55	1.77	3.54	1.11	0.66	3.32
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.79	26.54	2.65	0.38	1.52	0.38	1.14	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.22	10.80	0.85	0.57	1.42	1.42	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.73	13.76	0.49	0.49	1.47	0.25	0.49	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.25	29.98	1.96	0.65	0.65	0.65	3.26	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.82	16.76	1.18	0.59	2.06	0.59	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.96	22.78	1.44	0.58	1.44	1.15	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.96	22.67	0.41	1.65	2.06	0.82	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	16.97	1.49	1.19	1.19	2.38	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	7.13	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.04	8.54	0.99	0.33	0.00	1.31	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	6.31	0.00	0.00	0.00	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.51	5.14	0.40	0.00	0.20	0.79	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	10.24	0.93	0.00	2.79	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	17.27	10.14	0.00	0.38	1.13	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.79	8.79	0.27	0.53	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	12.33	9.84	0.45	0.11	0.57	0.45	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	17.68	5.16	0.74	0.00	0.74	0.00	0.74	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.59	5.13	0.73	0.00	0.37	0.37	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	10.89	1.56	0.00	0.00	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	4.28	0.53	0.00	0.53	0.00	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	7.07	0.00	3.03	3.03	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.22	8.01	0.00	0.00	0.00	0.84	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	5.45	0.00	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	4.53	0.00	0.00	1.51	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	17.13	0.00	0.00	0.00	0.00	0.00	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	3.26	0.00	0.00	3.26	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	9.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	15.51	14.22	0.43	0.22	0.65	0.43	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.29	14.63	0.52	0.00	2.09	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	1.33	0.67	0.00	2.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	3.76	0.00	0.00	0.83	0.00	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.69	17.68	0.95	0.57	0.19	0.57	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	51.07	57.45	4.79	7.98	4.79	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	55.13	3.68	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	0.42	0.42	0.00	0.84	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.07	5.35	0.23	0.23	0.00	0.46	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	1.08	1.08	0.00	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.14	10.93	0.63	0.63	0.63	1.68	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	55.67	22.27	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	1.49	0.50	0.50	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.20	4.06	0.81	0.00	0.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.29	1.36	0.23	0.00	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.10	2.45	0.33	0.16	0.00	0.65	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.59	11.85	1.28	0.36	0.18	0.36	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	3.71	0.00	0.53	0.00	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	1.80	0.00	0.60	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.10	16.08	0.00	0.00	0.66	0.00	0.98	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	1.63	0.49	0.00	0.00	0.00	0.65	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.22	14.64	0.88	0.53	0.53	0.88	0.00	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	2.11	0.70	0.00	0.00	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	3.68	0.46	0.92	0.92	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.21	2.57	0.32	0.32	0.00	0.00	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.21	22.07	0.34	0.34	0.34	0.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	68.27	106.19	12.64	10.11	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.06	13.59	1.78	0.00	0.22	0.00	1.78	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.04	6.35	0.00	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.39	4.75	0.00	0.47	0.24	0.24	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.73	0.43	0.00	0.00	0.43	0.43	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	108.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.66	4.33	0.67	0.00	0.67	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.99	12.62	0.90	1.35	0.90	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	1.59	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	1.86	0.93	0.00	0.00	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.86	6.43	0.38	0.00	0.00	0.00	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.47	2.93	0.98	0.00	0.33	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	3.05	0.44	0.44	0.00	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.52	20.35	1.81	0.45	0.90	0.00	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	1.76	0.00	0.00	0.00	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	2.66	0.00	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.93	2.98	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.40	1.15	0.38	0.00	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.89	6.05	0.30	0.00	0.60	0.30	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.54	10.83	0.88	0.22	0.66	0.44	0.88	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	71.53	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.85	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.55	3.15	0.00	0.00	0.31	0.63	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.41	2.72	0.30	0.00	0.00	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	0.79	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	21.54	1.13	1.13	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	65.75	45.52	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	10.44	13.54	0.99	0.50	0.37	0.99	0.37	0.12
Myoblast, donor2	11322-117D8	23.40	14.38	1.53	1.34	1.34	0.38	1.15	0.00
Myoblast, donor3	11398-118D3	14.46	14.97	1.51	1.35	0.67	1.18	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	75.30	20.58	4.82	1.61	0.29	0.15	1.75	0.73
Natural Killer Cells, donor1	11230-116C6	51.66	16.91	1.54	0.31	1.23	0.31	0.92	0.92
Natural Killer Cells, donor2	11311-117C6	47.65	17.19	1.81	0.00	0.60	0.00	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	50.25	18.04	1.29	1.10	0.74	0.18	1.29	0.37
Neural stem cells, donor1	11275-116H6	25.41	17.42	3.27	1.81	2.18	0.73	0.36	0.73
Neural stem cells, donor2	11352-117H2	46.22	21.18	3.85	3.85	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	26.17	22.76	4.55	0.00	1.14	0.00	2.28	0.00
Neurons, donor2	11574-120E8	36.99	18.49	0.22	1.10	0.44	1.98	0.66	0.00
Neurons, donor3	11655-122E8	27.13	15.62	0.82	1.64	0.82	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	21.34	33.41	1.86	4.64	1.86	0.00	0.00	1.86
Neutrophils, donor2	11314-117C9	31.89	23.19	0.00	11.60	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	11.61	23.82	0.00	0.61	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	21.02	16.15	2.61	0.24	0.12	0.12	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	13.02	8.47	1.30	0.98	0.00	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	13.64	11.23	0.60	0.40	0.40	0.00	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	15.14	8.40	0.28	0.41	1.38	0.41	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	18.82	9.55	1.16	0.43	0.58	0.87	0.43	0.43
Olfactory epithelial cells, donor3	11935-125I9	14.87	6.81	0.79	0.23	1.14	0.34	0.45	0.79
Olfactory epithelial cells, donor4	11936-126A1	22.01	11.01	1.27	0.19	0.39	1.07	0.49	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	43.93	15.65	0.60	0.00	0.00	1.20	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	15.53	10.42	1.06	0.21	0.43	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	6.86	4.57	0.00	1.14	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.76	8.69	0.62	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	14.85	8.01	0.78	0.39	0.00	0.39	0.20	0.39
Osteoblast, donor2	11354-117H4	32.31	21.77	4.21	1.40	2.11	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	20.62	17.06	1.78	0.53	0.00	0.36	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	22.74	14.24	1.35	1.18	0.67	0.42	0.08	0.34
Pericytes, donor1	11491-119E6	10.68	14.02	1.00	2.00	0.45	0.78	0.11	0.11
Pericytes, donor2	11571-120E5	13.81	15.85	0.91	1.36	1.13	0.45	0.23	0.23
Pericytes, donor3	11652-122E5	15.67	10.38	0.81	0.00	1.22	0.20	0.81	0.00
Perineurial Cells, donor1	11499-119F5	18.65	26.45	1.24	2.15	0.23	0.68	0.68	0.11
Perineurial Cells, donor2	11579-120F4	28.62	13.89	2.12	0.28	0.74	0.28	1.38	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.45	14.02	0.64	0.96	0.00	0.96	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.63	9.06	0.49	0.24	0.24	0.98	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	42.45	17.08	1.42	0.78	0.39	0.26	0.52	0.78
Placental Epithelial Cells, donor1	11278-116H9	24.39	13.87	0.48	0.00	1.43	1.91	0.00	0.96
Placental Epithelial Cells, donor2	11355-117H5	15.52	6.65	1.11	1.11	4.44	3.33	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	32.39	10.80	1.57	0.59	2.94	1.18	0.98	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	4.43	1.27	0.32	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	7.50	4.50	0.75	0.56	0.19	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.31	11.62	0.52	0.13	0.13	0.26	0.78	0.26
Preadipocyte - breast, donor2	11328-117E5	20.71	12.38	0.68	0.23	0.45	0.00	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	9.91	6.82	0.75	0.00	0.32	0.43	0.21	0.21
Preadipocyte - omental, donor2	11329-117E6	7.42	6.55	0.44	0.44	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	21.77	11.03	0.57	0.43	0.72	0.57	0.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	12.80	6.89	0.00	0.00	0.00	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	6.14	1.54	0.31	0.31	0.00	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.99	21.07	1.95	1.59	1.59	1.42	0.71	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	19.24	11.41	0.51	0.51	0.68	0.17	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	27.57	21.70	2.24	0.75	0.56	0.84	0.28	0.47
Preadipocyte - visceral, donor2	11357-117H7	26.69	15.65	0.92	0.00	0.92	0.92	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	22.36	13.79	0.73	0.63	1.57	0.73	1.15	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	40.28	22.18	1.36	3.32	1.21	0.91	0.30	0.45
Prostate Epithelial Cells, donor2	11331-117E8	11.92	10.29	1.35	0.54	1.49	0.27	0.41	1.22
Prostate Epithelial Cells, donor3	11404-118D9	19.66	9.86	1.22	0.18	1.59	0.73	0.55	0.98
Prostate Stromal Cells, donor1	11254-116F3	17.65	10.82	1.14	1.37	0.46	0.80	0.68	0.34
Prostate Stromal Cells, donor2	11332-117E9	23.31	11.65	1.26	0.90	0.72	0.36	0.36	0.36
Prostate Stromal Cells, donor3	11405-118E1	14.70	7.51	0.63	0.31	0.42	0.10	0.42	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	36.86	13.50	1.09	0.00	0.36	0.36	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.12	9.84	2.43	0.00	1.52	1.46	0.35	0.97
Renal Epithelial Cells, donor1	11517-119H5	21.81	12.68	2.03	0.51	1.52	1.01	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	29.16	14.94	4.27	1.42	1.42	0.71	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	23.61	12.92	2.54	0.21	1.16	1.38	0.11	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.74	7.49	0.00	1.36	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.01	8.62	0.94	1.21	0.67	0.54	0.27	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.30	16.43	2.44	2.22	1.55	0.67	0.67	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	12.64	3.99	2.00	0.00	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	24.21	14.97	2.42	0.88	0.66	0.66	0.66	0.22
Renal Mesangial Cells, donor2	11598-120H5	33.86	16.30	2.51	3.76	1.25	1.88	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	16.92	8.60	0.55	0.28	0.55	0.28	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	36.77	12.88	1.61	0.27	0.81	0.81	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.08	6.75	0.84	0.00	1.27	0.84	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.70	15.62	1.93	1.54	1.93	0.58	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.67	13.74	1.30	1.04	0.00	0.52	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.99	13.64	1.14	1.71	0.28	0.28	1.99	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	6.17	0.00	0.00	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.30	3.76	1.00	0.00	0.25	0.25	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	44.50	22.85	2.41	0.53	0.53	1.34	1.47	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	24.12	14.29	2.68	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	24.22	14.31	1.10	0.55	1.65	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	72.51	51.62	2.90	5.22	1.74	4.06	1.16	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	34.46	34.98	2.08	2.86	0.91	0.65	0.26	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	40.12	26.61	1.29	1.99	0.89	1.09	0.79	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.80	22.31	1.67	1.90	1.23	0.56	1.34	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.90	40.44	1.74	2.73	1.61	0.74	1.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	43.24	22.96	1.40	2.80	0.82	0.82	0.58	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.06	29.58	1.39	1.16	1.39	2.31	2.54	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.22	29.16	0.55	2.88	1.64	0.41	1.51	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	34.94	28.14	1.06	2.57	0.76	0.30	0.45	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.79	24.73	1.61	1.79	1.08	1.43	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	40.45	24.67	0.72	2.01	2.01	0.57	1.29	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	40.99	24.68	1.50	1.50	0.86	1.29	1.07	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.09	26.11	1.77	1.55	1.33	0.89	1.33	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	36.90	25.24	1.15	3.63	1.15	0.00	1.15	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	47.42	30.09	2.05	2.89	0.75	0.75	0.93	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.03	22.36	0.94	1.32	1.69	1.32	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	50.56	39.02	1.46	3.98	1.33	1.06	1.33	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	45.26	27.94	1.36	1.46	1.07	0.78	1.46	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	37.62	24.63	1.53	2.29	1.72	1.34	1.34	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.06	26.16	1.39	3.10	2.24	1.28	0.75	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	31.67	25.23	1.12	3.36	1.68	1.68	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	43.07	29.74	1.71	2.91	2.56	0.85	1.71	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.01	27.35	0.91	1.64	1.09	0.73	0.91	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	39.36	21.83	0.98	2.70	1.10	1.10	0.86	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.71	29.15	1.34	1.88	1.07	0.81	0.81	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	37.27	25.95	0.71	2.83	1.18	0.94	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.29	22.02	0.79	0.99	0.40	0.99	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	33.21	26.66	1.40	0.70	2.81	0.94	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	40.23	25.50	0.62	1.66	2.07	1.04	2.07	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	35.84	22.78	0.88	2.21	1.77	0.44	0.88	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	44.28	27.99	1.46	1.88	2.30	0.42	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.66	28.26	0.67	3.10	2.15	1.08	1.48	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	46.66	34.40	2.38	2.90	2.21	0.51	1.19	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	46.46	32.00	2.12	2.12	1.35	1.16	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	38.51	26.31	0.52	1.03	1.20	0.69	0.52	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	44.85	35.66	2.33	1.78	1.78	1.37	1.51	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	40.06	30.70	2.13	2.96	1.15	0.16	0.99	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.07	22.16	0.51	2.56	1.19	1.02	1.02	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	41.43	29.59	1.04	2.52	1.04	1.48	1.18	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	44.25	26.66	2.13	1.33	0.80	0.80	1.60	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	46.18	23.64	0.83	0.83	1.52	0.69	0.97	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.24	20.71	1.43	1.90	1.43	0.24	1.43	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	63.49	35.47	2.62	2.62	1.01	2.62	2.42	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.69	20.53	0.47	1.51	1.32	1.51	1.70	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	49.96	23.41	1.05	0.70	0.35	1.05	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	41.40	25.69	0.60	2.42	1.51	0.60	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	40.27	24.11	1.47	1.84	1.47	0.73	1.10	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	67.54	42.21	3.35	2.33	1.02	1.46	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.95	18.86	0.00	1.22	1.22	0.00	4.26	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	36.47	28.63	1.51	0.90	1.81	2.41	1.21	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	42.07	22.62	1.58	2.04	0.45	0.68	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	48.23	29.35	3.00	2.10	0.90	0.90	1.50	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	31.29	26.92	0.94	1.42	0.35	0.83	0.71	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	28.60	16.01	1.28	0.64	0.00	1.07	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.25	30.65	2.40	3.00	0.60	2.40	0.60	0.60
Schwann Cells, donor1	11498-119F4	27.83	20.12	3.39	2.07	1.13	1.13	0.75	0.19
Schwann Cells, donor2	11578-120F3	17.01	17.01	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.69	19.94	1.53	1.10	0.44	0.44	0.22	0.00
Sebocyte, donor1	11220-116B5	23.01	19.17	2.19	1.64	1.10	1.64	0.00	0.00
Sebocyte, donor2	11301-117B5	17.92	10.57	0.92	0.46	0.92	2.30	0.00	1.38
Sebocyte, donor3	11378-118B1	19.79	9.48	1.24	0.62	0.41	0.21	0.21	0.41
Sertoli Cells, donor1	11255-116F4	34.79	21.54	3.31	0.00	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	8.47	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	31.32	11.17	1.23	0.44	0.26	0.09	0.26	0.09
Skeletal Muscle Cells, donor2	11358-117H8	12.29	3.61	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	32.61	14.21	0.00	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	29.69	13.35	1.26	0.79	0.63	0.79	1.57	0.00
Skeletal Muscle Cells, donor5	11455-119A6	33.30	12.49	1.49	0.89	0.59	0.45	0.00	0.30
Skeletal Muscle Cells, donor6	11459-119B1	39.40	15.24	1.69	1.85	0.62	1.08	0.92	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.88	16.51	2.14	0.88	0.63	0.13	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.53	18.98	2.57	1.00	0.57	0.43	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	31.85	20.04	1.98	1.69	0.69	0.60	1.39	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	26.88	14.32	1.52	0.51	0.42	1.01	0.42	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	11.58	1.45	0.00	0.00	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.36	7.84	0.28	0.28	0.41	0.41	0.14	0.00
Skin - palm, donor1	10286-104F7	2.69	53.72	8.06	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.68	5.62	0.43	0.58	1.15	0.29	0.00	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	3.27	0.82	0.00	1.64	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.52	4.15	0.65	1.17	0.52	0.00	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	15.71	13.90	1.95	0.42	1.11	0.70	0.00	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	24.90	19.41	2.25	1.69	0.84	0.56	0.98	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.45	20.09	1.90	1.27	1.27	0.63	1.06	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	30.80	23.61	2.40	1.65	1.42	0.37	0.97	1.05
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.87	8.33	0.00	0.93	0.31	0.00	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	23.12	15.34	0.67	0.44	1.11	0.22	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	9.41	1.76	0.00	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.03	28.73	0.66	0.44	0.66	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	15.75	7.48	1.18	0.39	0.00	0.39	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.13	6.18	0.77	0.77	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	20.02	7.01	4.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.44	10.65	1.06	0.40	0.27	0.00	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.85	14.19	1.99	0.66	0.89	0.66	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.81	6.02	0.51	0.38	0.26	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.16	13.67	0.65	1.30	0.65	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	9.16	8.27	0.30	0.30	0.59	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	14.95	8.26	0.57	0.28	0.85	0.14	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.64	9.27	0.65	0.49	0.16	0.49	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.49	12.48	1.52	0.30	0.61	0.00	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.14	8.84	1.52	0.00	0.25	0.25	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	12.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	6.20	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.75	9.59	0.29	0.44	0.15	0.44	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.85	11.41	0.65	0.22	0.65	0.22	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	20.15	12.07	1.05	0.84	0.31	0.21	0.84	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.18	13.15	0.77	1.24	0.46	0.15	0.00	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	6.47	0.00	1.08	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.54	6.87	1.20	1.49	0.00	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	22.19	8.53	0.34	1.02	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.93	11.39	1.57	0.24	0.47	0.39	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.91	20.43	1.71	0.60	0.60	0.91	0.30	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.70	13.65	2.28	0.00	0.91	0.00	0.91	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.28	9.66	0.60	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.39	16.96	2.12	1.32	1.59	0.79	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.37	17.71	1.86	0.80	0.53	0.67	0.80	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.16	9.27	1.13	1.13	0.63	0.13	0.63	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.85	3.04	0.51	0.25	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	24.88	15.38	1.81	1.21	0.60	0.90	0.45	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	6.75	1.50	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	151.19	2.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.00	13.02	0.93	0.93	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	22.72	11.61	1.51	2.52	1.01	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.15	5.01	0.00	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.91	11.50	1.47	0.29	0.29	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	50.40	28.57	2.50	2.25	1.42	1.42	1.33	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.62	13.55	0.93	0.00	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.23	10.65	1.01	0.58	0.29	0.14	0.14	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.59	11.73	0.76	0.51	0.76	0.25	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.29	7.15	0.56	0.56	0.00	0.38	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	34.38	17.05	1.82	0.56	1.54	1.54	1.26	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.52	8.21	0.25	0.34	0.34	0.00	0.34	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.90	6.67	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.68	7.34	1.22	0.49	0.24	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.14	9.50	1.55	0.66	0.66	0.66	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.29	4.97	1.17	0.29	0.29	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.02	7.00	1.55	0.39	0.19	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	7.67	1.59	0.26	0.26	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.58	2.98	0.37	0.00	0.00	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.06	7.91	0.36	0.36	0.00	0.00	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.37	4.26	1.99	1.14	0.57	0.57	0.00	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.94	8.67	1.18	0.79	0.39	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.17	5.08	0.51	1.02	0.00	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	11.18	4.79	0.80	0.00	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	11.70	5.85	0.42	0.00	0.42	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	10.08	5.04	1.38	0.00	0.00	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	15.15	8.92	0.84	0.34	0.34	0.17	0.17	0.17
Synoviocyte, donor2	11368-117I9	17.10	9.22	1.01	0.17	0.67	0.00	0.84	0.17
Synoviocyte, donor3	11440-118H9	16.31	9.61	0.45	0.45	0.22	0.22	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	38.95	15.37	1.79	1.07	0.71	1.43	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	7.93	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	32.42	9.96	2.08	1.62	0.23	1.16	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	18.85	9.75	1.36	0.36	0.43	0.36	0.29	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	6.96	4.25	0.39	0.00	0.77	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	5.15	0.57	0.57	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	47.36	23.50	1.11	0.49	0.37	1.72	0.62	1.60
Urethra, donor2	10319-105A4	41.36	21.58	3.60	1.80	1.80	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	18.60	10.10	1.59	0.80	1.86	1.33	0.00	0.27
Urothelial Cells, donor2	11600-120H7	15.22	8.41	0.00	0.00	2.00	0.00	0.80	0.80
Urothelial Cells, donor3	11681-122H7	16.50	7.11	0.92	0.00	0.23	0.00	0.69	0.23
Urothelial cells, donor0	11216-116B1	27.19	15.60	1.11	0.00	1.11	1.11	0.22	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	66.73	26.69	2.67	0.00	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	54.33	38.60	0.00	2.86	0.00	0.00	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	28.75	0.68	0.00	0.68	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.06	18.25	2.75	0.69	0.34	0.34	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	37.77	21.50	1.16	1.16	1.74	0.00	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	51.02	17.70	1.04	3.12	0.00	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	59.66	22.03	2.75	1.84	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	40.17	15.52	0.00	1.83	2.74	0.00	0.00	2.74
Wilms' tumor cell line:G-401	10809-111A8	30.96	19.74	2.10	1.85	0.99	0.74	1.85	0.62
Wilms' tumor cell line:HFWT	10597-108E3	19.36	13.20	4.40	1.76	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.71	12.01	2.51	0.84	2.51	1.68	1.68	0.28
achilles tendon, donor2	10292-104G4	14.47	26.86	2.07	0.00	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	40.03	12.49	3.06	0.51	0.51	0.51	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	73.60	17.41	2.32	2.55	0.70	2.32	0.93	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	50.81	27.90	3.09	3.32	0.71	0.36	0.95	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	39.73	16.05	1.90	1.63	1.09	1.36	0.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	36.26	12.37	1.69	1.12	0.84	0.84	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.40	10.57	0.42	0.21	0.63	0.63	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	33.48	12.25	5.17	1.09	0.27	0.27	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.78	10.13	0.88	2.64	1.32	0.88	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	35.94	14.29	1.63	2.86	0.41	0.00	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	29.51	20.19	1.94	5.44	1.16	0.39	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	24.66	16.56	2.21	4.97	0.55	0.37	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	23.40	3.90	7.80	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	28.82	25.79	2.79	2.09	0.23	1.39	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	55.92	15.02	2.59	2.85	2.07	1.55	0.00	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.76	28.06	1.75	4.97	0.88	1.17	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	49.26	17.20	2.32	5.11	1.39	1.39	1.39	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.68	2.88	0.82	0.00	1.65	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.81	10.44	1.53	2.46	0.00	0.92	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	22.19	17.50	1.28	1.71	0.85	0.00	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	20.32	13.65	1.52	1.52	0.30	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.16	12.76	1.68	4.09	0.72	0.96	0.24	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.60	6.46	0.22	0.67	0.67	0.22	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	50.03	17.01	4.34	1.67	5.00	1.33	1.00	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	100.34	53.89	1.86	1.86	1.86	5.57	5.57	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	29.00	9.04	3.77	3.39	2.26	1.51	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	85.48	18.32	0.00	1.74	3.49	0.44	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	127.46	33.74	18.74	3.75	1.87	1.87	9.37	1.87
adenocarcinoma cell line:IM95m	10796-110I4	65.00	27.79	3.53	0.47	1.88	0.47	2.83	0.94
adipose tissue, adult, pool1	10010-101C1	38.62	17.68	1.55	0.31	0.47	0.31	0.16	0.31
adipose, donor1	10184-103D4	54.54	27.56	4.10	6.45	4.69	3.52	2.35	1.76
adipose, donor2	10185-103D5	18.65	7.70	1.22	0.00	0.00	2.03	1.22	0.00
adipose, donor3	10186-103D6	21.78	22.60	1.91	0.82	1.09	0.82	2.18	1.09
adipose, donor4	10187-103D7	19.07	63.27	5.20	0.87	3.47	2.60	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	87.27	34.56	3.16	2.05	3.00	2.21	4.26	2.53
adrenal gland, adult, pool1	10081-102A9	25.46	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.62	13.87	7.34	0.27	0.93	1.33	0.67	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	17.86	16.79	0.36	1.79	0.00	0.00	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	12.75	14.14	0.46	0.46	0.70	3.48	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	15.21	23.67	1.01	0.34	1.01	3.04	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	18.85	28.87	1.18	0.00	1.77	5.01	0.59	2.95
amygdala - adult, donor10196	10167-103B5	16.60	53.36	2.37	1.19	2.37	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	47.04	91.85	4.06	0.81	1.62	1.42	2.64	0.41
amygdala, newborn, donor10223	10360-105E9	11.62	11.94	2.58	0.65	0.97	0.65	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	14.39	7.51	0.64	0.13	0.13	0.13	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	34.64	5.74	0.00	0.44	0.88	1.32	1.99	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	51.78	35.74	4.68	1.00	0.67	1.00	0.67	0.33
aorta, adult, pool1	10052-101G7	57.27	24.12	2.75	0.20	0.39	1.18	1.77	0.20
appendix, adult	10189-103D9	74.52	23.29	2.72	0.78	1.94	0.78	1.16	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	44.37	12.38	2.75	1.38	0.69	1.03	1.38	0.69
artery, adult	10190-103E1	40.76	12.23	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	32.31	16.51	3.19	0.58	0.72	0.29	0.14	0.29
b cell line:RPMI1788	10427-106D4	38.51	15.46	2.97	1.49	0.59	0.30	0.45	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.16	8.32	0.28	0.28	0.00	0.55	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	47.23	18.56	1.79	2.58	2.18	0.99	0.99	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	26.28	7.36	0.84	0.50	0.17	0.67	0.33	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	16.78	18.45	1.68	3.91	0.56	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	55.30	23.90	3.26	0.33	0.11	0.87	0.76	0.22
blood, adult, pool1	10053-101G8	31.00	11.07	0.00	0.00	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	8.56	24.83	4.28	0.86	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	35.09	11.47	1.35	0.67	2.02	1.35	0.67	0.00
brain, adult, donor1	10084-102B3	19.48	43.05	3.08	2.05	2.05	1.03	2.05	1.03
brain, adult, pool1	10012-101C3	28.28	64.37	5.46	2.45	0.89	1.56	1.34	0.11
brain, fetal, pool1	10085-102B4	37.40	21.37	0.00	0.00	2.67	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	44.27	24.78	1.32	2.97	4.29	2.97	2.64	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	41.32	35.95	2.12	2.87	5.12	7.61	0.62	2.62
breast, adult, donor1	10080-102A8	32.20	5.05	0.63	0.00	2.53	1.26	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	36.71	13.34	0.64	3.56	0.89	1.14	0.76	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	46.69	19.48	1.24	1.24	0.62	0.00	2.16	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.03	7.60	1.15	0.00	1.61	2.07	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	22.03	0.48	1.69	2.91	2.42	0.00	3.15
carcinoid cell line:NCI-H1770	10703-109H1	54.07	18.34	4.23	0.47	0.94	1.41	1.88	0.47
carcinoid cell line:NCI-H727	10735-110B6	76.02	43.10	10.50	2.73	2.08	0.55	1.42	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	15.21	10.46	2.22	1.27	0.00	0.32	1.27	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	42.32	18.90	1.33	0.80	1.33	0.53	1.06	1.33
caudate nucleus - adult, donor10196	10177-103C6	24.18	56.41	8.06	1.15	0.00	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	38.65	111.77	7.36	2.68	1.34	1.34	1.84	1.34
caudate nucleus, adult, donor10258	10379-105H1	24.45	39.74	3.06	0.00	2.29	3.06	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	15.75	12.09	1.46	0.37	0.73	1.10	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	55.35	84.48	11.65	0.00	2.91	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	74.09	129.17	6.83	6.19	1.71	2.56	4.70	1.92
cerebellum, adult, pool1	10083-102B2	37.60	39.67	2.76	1.03	0.34	1.03	3.45	0.34
cerebellum, newborn, donor10223	10357-105E6	52.31	39.02	3.32	2.49	2.49	3.32	0.00	0.83
cerebral meninges, adult	10188-103D8	23.45	58.75	5.04	1.76	0.50	1.01	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	21.20	21.20	0.00	0.00	0.00	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	17.40	9.20	0.43	1.15	3.16	2.73	0.43	1.29
cervical cancer cell line:ME-180	10553-107I4	30.66	10.11	1.33	0.99	1.66	0.83	0.50	0.83
cervix, adult, pool1	10013-101C4	65.30	19.63	2.73	0.21	0.21	1.47	1.89	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.16	5.99	0.14	0.56	0.56	0.14	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	27.43	5.23	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	19.26	6.21	0.37	0.75	0.99	1.74	0.25	0.25
choriocarcinoma cell line:SCH	10785-110H2	14.79	6.41	2.09	0.74	1.11	1.11	0.62	2.34
choriocarcinoma cell line:T3M-3	10618-108G6	38.19	14.47	0.95	1.66	1.19	0.95	1.42	0.71
chorionic membrane cells, donor1	12238-129G6	16.24	12.25	0.57	0.28	1.14	0.85	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	21.48	17.90	1.79	0.50	0.99	1.19	0.20	0.50
chorionic membrane cells, donor3	12240-129G8	21.43	12.09	1.10	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	6.06	0.00	2.02	0.00	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.78	10.18	1.73	0.96	0.96	0.19	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	77.51	19.22	5.28	2.32	0.63	0.42	1.48	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	51.10	14.64	1.28	1.28	2.05	1.54	1.80	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	60.23	15.24	1.94	2.42	1.45	2.42	1.94	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	45.41	13.85	1.02	0.41	1.83	1.22	2.04	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	29.15	9.72	2.36	0.88	0.88	2.36	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	106.86	14.07	4.17	1.04	1.30	1.04	1.56	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	18.06	7.77	1.37	0.23	0.23	0.46	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	11.97	9.89	1.56	0.87	0.69	0.52	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	18.85	22.70	1.28	3.29	0.55	0.92	0.18	0.73
colon carcinoma cell line:COLO-320	10420-106C6	40.67	14.44	1.90	1.52	0.76	0.38	1.14	0.00
colon, adult, donor1	10082-102B1	64.26	20.23	1.19	0.00	0.00	0.00	2.38	3.57
colon, adult, pool1	10014-101C5	82.84	36.66	3.53	1.29	0.47	1.06	2.12	0.12
colon, fetal, donor1	10070-101I7	33.99	12.98	1.24	0.00	0.00	1.24	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	77.92	64.17	0.00	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	15.72	13.60	1.70	0.00	0.42	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.98	18.41	1.81	0.91	0.60	0.45	0.15	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	22.84	18.75	0.85	0.56	0.42	0.85	0.42	0.42
corpus callosum, adult, pool1	10042-101F6	63.57	42.23	3.65	1.44	1.33	2.43	1.11	0.55
cruciate ligament, donor2	10295-104G7	17.02	14.59	1.62	0.81	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	31.30	4.82	0.00	0.80	0.00	0.80	3.21	0.00
diencephalon, adult	10193-103E4	26.88	38.64	4.08	1.20	0.96	1.20	0.48	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	55.34	21.35	5.51	2.98	1.61	0.46	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.77	18.72	2.82	0.51	2.05	0.77	0.00	2.56
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.24	13.96	8.18	0.24	1.44	1.69	1.69	0.96
ductus deferens, adult	10196-103E7	50.33	25.91	5.98	1.00	0.50	1.00	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	7.20	2.88	1.44	1.44	2.88	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	19.13	2.94	0.74	0.74	1.47	0.00	2.94
dura mater, adult, donor1	10041-101F5	40.55	24.28	2.73	1.40	1.16	1.07	0.99	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	14.43	9.33	11.99	2.22	1.78	0.22	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	11.61	14.19	4.73	2.72	1.15	1.15	0.43	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	33.91	12.33	1.85	0.00	1.85	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.56	5.45	0.30	0.30	0.00	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	26.55	10.19	0.62	1.23	1.54	0.62	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	30.21	28.90	0.00	1.31	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	19.44	15.08	4.36	0.00	0.00	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	28.09	16.13	1.27	0.36	0.36	0.00	1.81	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.83	7.88	1.13	0.00	0.80	0.64	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	42.46	23.68	5.45	2.89	2.45	1.78	1.11	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	35.09	26.18	0.99	3.30	2.97	2.75	0.66	1.98
epididymis, adult	10197-103E8	35.16	20.51	2.51	0.21	1.47	0.84	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.93	6.39	1.24	0.18	0.53	0.18	0.71	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.51	11.01	1.18	1.57	0.00	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	56.48	30.67	1.83	3.41	3.41	2.88	3.80	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	57.38	31.49	1.18	3.84	2.66	2.07	3.05	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.33	31.70	1.01	3.92	2.58	3.02	3.25	3.25
esophagus, adult, pool1	10015-101C6	48.74	26.01	3.50	0.64	1.27	1.49	0.85	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	39.32	20.29	3.38	1.38	0.63	1.38	1.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	57.95	19.32	7.24	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	6.31	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	43.16	19.35	2.98	0.00	0.00	0.00	4.46	0.00
eye - muscle superior, donor2	10297-104G9	25.22	20.64	1.15	1.15	0.00	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	20.40	5.83	1.46	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	41.44	19.07	2.54	0.51	1.27	2.54	2.03	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	25.52	6.67	0.26	0.77	0.77	0.51	0.90	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	66.48	23.74	2.61	4.04	2.14	1.42	1.66	0.71
frontal lobe, adult, pool1	10040-101F4	33.78	83.41	5.54	2.53	1.22	1.22	1.03	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	45.64	25.82	1.80	2.40	5.10	2.40	0.60	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	18.84	8.41	0.64	0.09	0.09	0.73	0.46	0.27
gall bladder, adult	10198-103E9	67.60	20.28	2.90	0.72	1.69	0.48	0.72	1.21
gamma delta positive T cells, donor1	11937-126A2	31.67	4.29	0.54	0.00	0.00	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	23.53	7.47	0.75	0.00	0.37	0.00	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	18.59	9.93	0.84	2.75	1.06	0.21	0.00	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	67.70	22.63	2.13	0.77	0.58	0.58	2.51	0.58
gastric cancer cell line:AZ521	10549-107H9	56.24	18.20	1.97	2.13	1.48	1.15	0.98	0.49
gastric cancer cell line:GSS	10560-108A2	43.93	8.24	1.83	0.00	0.00	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	45.46	15.08	2.74	0.91	1.37	0.69	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	15.38	2.18	0.46	0.11	0.46	0.34	0.23	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	17.91	6.02	0.98	0.28	0.42	1.26	0.42	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	53.87	30.93	2.74	2.00	2.74	1.25	1.50	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	20.37	25.54	1.16	1.27	0.63	0.53	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.50	23.87	1.83	1.69	0.84	1.83	0.42	0.28
glioblastoma cell line:T98G	10485-107A8	24.17	18.65	3.31	1.55	0.77	0.88	0.77	0.11
glioma cell line:GI-1	10413-106B8	21.09	15.82	1.46	0.59	0.59	0.88	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	29.16	31.34	3.64	0.73	2.19	2.19	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	84.21	75.18	5.37	2.44	1.71	5.13	3.42	1.46
globus pallidus, adult, donor10258	10367-105F7	34.23	20.54	2.74	0.00	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	12.79	7.46	1.60	1.07	1.07	0.00	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	34.26	4.89	9.79	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.48	14.08	0.64	0.32	0.00	0.64	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	20.20	7.80	1.84	1.84	2.75	2.30	0.00	2.75
hIPS +CCl2, biol_rep2	14384-156C1	19.21	4.57	0.91	3.20	3.66	2.74	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	18.68	7.73	1.93	1.29	3.86	2.58	0.00	0.00
hIPS, biol_rep1	14380-156B6	12.94	0.00	0.00	1.44	5.75	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	21.95	4.12	2.06	4.12	2.74	1.37	0.69	0.69
hIPS, biol_rep3	14382-156B8	22.07	44.14	6.62	4.41	2.21	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	44.25	20.98	1.44	2.01	2.01	0.86	0.57	1.15
heart - mitral valve, adult	10205-103F7	42.45	20.93	1.20	0.30	0.30	0.60	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	65.89	31.64	3.40	0.52	0.00	0.52	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	71.61	24.15	1.67	0.00	0.00	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	29.38	14.49	1.22	0.61	1.63	1.43	1.63	1.63
heart, adult, diseased, donor1	10051-101G6	35.34	17.46	0.85	0.43	0.43	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	40.94	30.59	2.53	0.46	0.46	0.69	0.46	0.23
heart, fetal, pool1	10046-101G1	60.07	24.64	3.70	0.21	0.21	1.64	1.03	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	26.53	12.96	1.54	0.31	0.93	0.93	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	88.00	30.92	2.38	2.38	1.19	0.00	2.38	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	35.36	24.20	3.20	2.54	0.66	1.22	1.55	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	32.53	24.40	3.03	3.52	2.31	1.82	1.58	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.24	27.69	3.03	3.64	2.02	1.72	2.22	1.52
hepatoma cell line:Li-7	10484-107A7	23.02	18.46	1.45	3.23	1.22	0.56	0.78	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	47.64	15.58	2.21	2.41	1.91	0.40	2.41	1.41
hippocampus - adult, donor10196	10169-103B7	18.93	35.96	9.46	2.84	0.95	1.89	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	50.62	90.21	3.88	2.65	1.84	1.63	2.86	0.61
hippocampus, adult, donor10258	10374-105G5	17.43	42.82	4.48	1.00	1.49	0.50	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	17.98	14.10	1.41	0.70	1.06	1.76	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	30.52	12.21	3.05	1.83	4.88	8.54	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	19.64	4.32	1.37	0.79	2.36	3.53	0.20	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	21.58	3.05	0.76	0.76	3.05	4.57	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.27	6.77	2.82	1.13	2.26	4.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.44	9.04	1.03	2.32	1.55	2.07	0.77	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	21.64	9.11	1.90	2.66	1.90	2.66	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.27	11.97	2.63	1.46	1.17	1.46	0.00	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	20.68	13.14	2.37	0.65	0.86	0.43	0.86	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.01	10.43	2.50	1.67	1.67	1.25	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	8.29	12.08	1.89	0.95	0.47	1.42	0.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.96	12.21	2.09	2.25	0.48	1.45	0.16	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	10.10	0.67	0.67	0.00	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.91	3.91	0.94	0.31	2.03	3.44	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	21.13	3.44	1.47	1.97	1.97	3.93	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.95	6.11	0.00	3.49	5.24	5.24	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.11	9.35	1.53	1.34	0.95	3.05	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	25.29	12.21	2.18	2.18	2.18	1.74	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	22.99	7.00	0.50	1.00	1.50	1.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.22	11.49	1.32	0.94	0.38	0.75	0.75	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	24.10	11.37	1.82	1.82	0.91	0.45	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.84	9.08	0.00	1.57	1.57	0.63	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.74	9.31	1.47	1.63	0.49	0.33	0.33	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.55	11.32	1.16	1.45	1.74	0.29	0.87	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	14.05	6.88	1.49	1.79	2.99	0.00	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.46	5.54	1.48	0.92	2.59	4.25	0.37	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.11	6.28	1.14	2.57	1.43	4.56	0.86	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	33.89	8.17	2.45	4.90	3.67	4.08	1.22	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	29.57	10.21	1.41	1.76	0.70	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.24	6.02	2.22	0.63	0.95	0.63	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	21.18	10.89	0.91	0.30	1.51	2.42	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	15.51	11.38	0.00	2.07	1.03	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.27	9.96	2.66	1.99	1.33	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.85	12.83	2.31	0.77	1.03	1.80	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.55	15.34	1.28	1.53	0.51	0.77	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	11.36	21.96	1.51	0.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.43	11.43	0.67	0.67	2.35	0.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	31.40	6.28	1.93	1.93	2.90	3.86	0.48	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	8.02	0.89	1.78	4.90	3.12	0.00	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	33.17	2.93	1.95	1.95	1.46	3.41	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	36.06	10.39	0.61	2.44	0.92	1.83	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	133.38	91.09	3.25	6.51	6.51	16.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	29.12	12.58	2.32	2.32	1.65	2.32	0.33	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.06	20.25	2.74	2.19	0.55	1.09	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	18.09	11.58	1.81	2.90	1.09	1.81	0.36	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	17.44	14.59	1.42	0.71	1.42	1.78	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	7.16	1.19	0.00	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.25	16.79	2.71	2.71	1.22	0.27	0.14	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.12	12.39	2.16	1.08	1.35	0.54	0.00	0.27
immature langerhans cells, donor1	11904-125F5	4.36	12.59	1.45	2.66	0.24	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	5.54	7.13	0.79	0.00	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	33.41	82.14	6.25	2.08	1.04	1.99	1.04	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	15.61	7.80	0.65	0.98	1.95	0.00	0.65	0.98
kidney, adult, pool1	10017-101C8	41.65	21.03	2.70	0.50	1.10	0.90	1.00	0.90
kidney, fetal, pool1	10045-101F9	49.66	22.21	3.11	0.78	0.78	1.63	0.78	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	42.75	16.76	1.42	1.56	0.57	0.14	1.42	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.43	5.67	0.14	0.28	0.28	0.14	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	37.98	16.88	1.28	1.28	1.47	1.28	0.92	1.10
left atrium, adult, donor1	10079-102A7	29.42	4.90	0.54	0.00	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	32.87	11.12	2.02	0.51	0.00	1.01	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	34.75	13.68	1.92	0.55	0.82	0.27	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	8.26	6.47	0.36	0.72	0.00	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	4.35	4.89	0.00	0.54	0.00	0.54	0.54	0.54
leiomyoma cell line:15425	10571-108B4	10.93	9.23	0.97	0.24	0.24	0.49	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	4.18	0.00	0.00	1.05	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	62.10	18.42	5.55	1.42	1.77	0.83	2.13	0.47
liposarcoma cell line:KMLS-1	10782-110G8	10.15	14.37	0.47	0.94	0.62	0.62	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	36.92	26.20	2.68	1.83	1.10	1.10	1.58	0.61
liver, adult, pool1	10018-101C9	25.93	7.94	0.97	0.32	0.00	0.49	0.81	0.16
liver, fetal, pool1	10086-102B5	27.28	2.82	1.88	0.00	0.00	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	34.56	39.66	5.83	3.35	1.02	0.73	1.02	0.73
locus coeruleus, adult, donor10252	10165-103B3	48.17	57.95	5.17	1.66	1.66	2.40	2.77	1.11
locus coeruleus, adult, donor10258	10375-105G6	17.77	10.72	2.26	1.13	0.00	0.00	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	18.51	21.03	3.79	0.42	1.26	0.42	0.42	1.68
lung adenocarcinoma cell line:A549	10499-107C4	25.88	15.09	2.21	0.42	0.69	0.42	0.28	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	55.15	23.44	0.69	0.69	2.07	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	38.23	18.19	2.24	0.40	0.40	0.00	0.92	0.13
lung, adult, pool1	10019-101D1	49.02	15.95	1.77	0.35	0.47	0.35	0.83	0.12
lung, fetal, donor1	10068-101I5	79.91	28.83	3.14	1.14	0.86	1.71	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	47.65	11.46	0.00	0.46	0.46	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	43.55	11.36	0.47	0.47	0.00	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	38.14	11.84	2.85	0.88	1.32	0.88	1.53	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	23.54	7.85	1.51	0.75	0.15	0.00	0.60	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	44.17	27.18	0.85	2.55	2.55	1.70	0.00	2.55
mature adipocyte, donor1	12231-129F8	14.21	16.87	3.11	0.00	0.44	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	10.79	12.24	1.87	0.21	0.00	0.21	0.42	0.00
mature adipocyte, donor3	12233-129G1	13.04	12.56	3.56	0.24	0.24	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	13.42	17.90	6.05	0.00	0.00	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.94	16.68	1.43	0.95	1.19	1.91	0.71	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	76.71	4.51	4.51	2.26	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	45.61	125.61	6.62	3.86	2.02	1.66	2.94	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	14.30	38.44	4.77	1.27	0.64	0.64	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	17.91	37.96	4.26	4.69	1.71	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	24.98	64.97	5.23	2.70	0.84	1.01	0.84	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	51.57	127.55	7.64	3.61	1.49	2.12	2.33	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	19.26	3.85	3.85	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	287.07	0.00	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.00	14.36	1.08	0.00	1.79	0.72	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	22.71	20.12	3.24	0.65	0.00	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	56.81	59.44	4.18	1.55	0.77	2.17	3.87	0.31
medulla oblongata, adult, pool1	10038-101F2	42.77	52.24	5.22	2.86	0.65	1.71	0.90	0.57
medulla oblongata, newborn, donor10223	10361-105F1	24.30	15.28	2.08	1.74	1.39	1.74	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	94.54	18.38	5.31	2.66	1.55	2.66	1.11	0.66
medulloblastoma cell line:ONS-76	10759-110E3	43.77	27.63	7.83	5.26	1.10	1.22	1.10	0.86
melanoma cell line:COLO 679	10514-107E1	18.69	16.10	3.59	1.58	0.86	0.00	0.86	1.44
melanoma cell line:G-361	10465-106H6	11.40	14.66	3.53	0.81	0.54	0.81	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	15.74	5.97	2.53	0.00	0.72	0.54	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	97.81	36.13	7.05	7.93	3.52	5.29	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	41.73	25.92	3.63	3.63	1.56	2.85	0.52	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.72	21.48	1.07	1.07	0.31	0.15	0.77	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.72	16.36	1.27	0.36	0.00	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.52	15.74	0.83	0.83	0.83	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.86	14.47	0.14	0.42	0.00	0.00	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.03	11.94	0.19	0.39	0.39	0.00	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	8.33	0.69	0.00	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.81	6.18	1.20	0.00	0.00	0.34	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.25	14.38	0.35	0.00	0.46	0.46	1.15	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.97	14.46	0.66	0.93	0.27	0.93	1.19	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.93	14.04	0.68	0.54	0.81	0.81	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.78	19.06	1.56	1.00	0.85	0.28	1.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.52	5.27	0.33	0.00	0.33	0.66	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.76	16.60	0.97	0.97	0.28	0.28	0.69	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.03	13.96	0.35	0.35	0.00	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.86	16.74	0.61	0.41	0.20	0.41	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.47	6.47	1.80	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	17.07	12.52	0.72	0.10	0.10	0.31	0.72	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.02	5.02	0.46	0.46	0.46	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.56	19.30	2.10	0.42	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.39	12.85	0.60	0.45	0.30	0.00	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.27	11.82	1.05	0.53	0.09	0.26	1.05	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.47	7.00	0.74	0.00	0.00	1.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.73	5.72	0.86	0.86	0.57	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	19.79	17.26	2.11	0.84	0.00	0.84	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.81	9.13	1.37	0.46	1.37	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.02	6.91	0.26	0.51	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.99	8.11	0.52	0.00	0.00	0.52	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.86	10.47	1.23	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.06	9.18	0.94	0.47	0.00	0.00	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.23	11.17	0.34	0.00	0.34	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.43	6.68	1.18	0.00	0.00	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	6.95	1.85	0.00	0.00	0.93	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.02	9.52	0.29	0.00	0.00	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.62	8.92	0.89	0.22	0.00	0.00	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.46	11.78	0.96	0.24	0.24	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	11.73	0.00	0.00	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.42	11.08	1.68	0.67	0.00	0.00	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	8.19	0.82	0.00	0.00	0.00	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.03	8.16	0.43	0.00	0.43	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	2.73	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	3.90	3.25	1.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	7.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.40	4.80	0.53	0.00	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.91	7.36	1.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	4.66	1.17	0.00	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	6.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	2.98	1.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	7.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	2.44	1.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	3.17	0.00	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	6.21	0.69	0.00	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	6.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.19	8.15	2.04	0.81	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	2.38	0.00	0.79	0.00	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	2.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.66	6.55	1.25	0.00	0.00	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	2.67	1.34	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	4.73	0.00	1.18	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.26	6.20	1.38	1.38	0.00	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.88	4.95	1.48	0.99	1.48	0.49	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	5.61	2.24	0.00	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	5.09	1.91	0.00	1.91	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.87	6.04	2.82	0.00	0.40	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	8.72	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	5.07	1.27	0.00	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	20.63	11.53	1.82	1.21	0.00	0.00	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	4.94	3.29	0.82	0.82	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.56	2.18	1.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.09	3.24	0.65	0.32	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	4.07	3.06	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	10.06	0.77	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	33.31	17.01	1.89	0.00	1.18	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.00	15.29	3.48	0.46	0.70	0.70	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.73	5.14	0.62	0.72	0.31	0.00	0.21	0.31
mesothelioma cell line:Mero-25	10850-111F4	16.79	5.67	1.36	0.68	0.68	0.23	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	14.91	7.82	1.22	0.24	0.98	0.24	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	19.04	11.96	2.21	0.44	1.11	0.66	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	33.64	13.67	4.73	1.31	1.58	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	18.89	9.36	2.04	0.85	1.70	0.85	0.17	0.68
mesothelioma cell line:Mero-84	10855-111F9	21.74	5.31	1.01	0.25	1.52	0.51	0.76	0.76
mesothelioma cell line:Mero-95	10856-111G1	13.66	8.07	1.04	0.83	0.41	1.04	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	31.47	21.70	2.82	2.65	0.66	0.50	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	11.04	14.12	0.90	1.09	1.09	0.54	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	30.75	10.08	2.22	0.68	1.02	0.17	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	14.25	4.58	0.00	0.25	0.76	0.25	0.25	0.76
mesothelioma cell line:No36	10857-111G2	18.92	5.55	0.65	1.63	0.65	0.65	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	15.17	7.04	0.54	1.08	0.27	0.27	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	15.16	12.67	1.34	0.19	0.00	0.00	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	15.26	9.53	0.73	0.24	0.49	0.85	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	10.77	9.51	1.26	0.18	0.36	1.08	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	17.30	10.77	0.98	0.33	0.65	0.98	1.31	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	13.14	7.21	0.85	0.64	0.00	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	41.69	29.26	2.76	2.30	0.92	0.23	2.30	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.92	15.41	0.38	0.57	0.57	0.38	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	18.85	8.32	1.48	1.48	0.92	0.18	0.55	0.74
myeloma cell line:PCM6	10474-106I6	28.86	7.91	0.59	0.59	0.00	0.20	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	35.51	22.32	2.03	0.00	1.52	4.06	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.04	15.10	2.55	0.98	0.39	0.39	1.57	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.81	7.35	1.34	0.00	0.78	0.33	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.25	6.55	1.25	0.15	0.44	0.44	0.29	0.29
nasal epithelial cells, donor2	12227-129F4	9.38	25.39	2.76	0.00	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	62.35	38.19	5.29	3.45	1.38	0.69	2.07	0.23
neuroblastoma cell line:NB-1	10539-107G8	58.37	36.11	6.17	1.12	1.68	2.25	1.68	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	19.61	40.49	3.16	6.33	0.84	0.63	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	72.86	25.16	3.73	3.73	3.54	2.80	1.49	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	35.11	19.22	2.14	1.42	0.71	0.47	0.47	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	47.04	25.82	2.22	1.90	0.63	0.79	3.33	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	24.35	14.29	1.41	2.82	0.81	0.20	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.17	59.13	2.54	10.81	3.18	1.27	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	17.83	15.97	0.53	0.53	0.27	0.27	0.80	0.00
neutrophil PMN, donor1	12133-128D9	14.87	104.12	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	86.08	22.32	5.75	4.57	0.85	0.68	0.68	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	7.20	4.00	0.00	0.00	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	6.73	1.28	0.64	0.32	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.19	9.99	1.31	0.00	0.00	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	33.75	84.55	6.09	3.00	1.41	1.97	0.66	0.66
occipital cortex - adult, donor10196	10172-103C1	32.97	103.02	4.12	0.00	0.00	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	66.55	111.10	7.51	5.64	1.07	2.15	4.56	1.07
occipital cortex, newborn, donor10223	10355-105E4	14.56	30.94	2.91	0.36	1.82	2.55	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	29.39	50.91	5.77	1.84	1.31	2.10	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	49.78	14.16	4.72	1.29	3.00	2.15	0.43	0.00
occipital pole, adult, pool1	10036-101E9	28.38	64.57	5.28	2.44	0.55	1.50	1.02	0.55
olfactory region, adult	10195-103E6	40.12	75.08	6.50	2.67	0.38	0.76	0.96	0.38
optic nerve, donor1	10277-104E7	44.02	28.01	10.01	2.00	2.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	20.62	8.32	0.68	0.23	0.91	1.48	0.34	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.36	10.30	1.92	0.27	1.79	0.82	0.82	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.45	9.14	0.68	1.35	2.03	1.69	0.85	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	35.23	13.86	1.16	1.50	1.04	0.12	1.50	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	10.88	2.06	0.59	0.29	0.59	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	46.72	75.68	9.34	6.54	1.87	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	25.45	6.15	0.85	0.42	0.42	1.27	0.42	0.64
ovary, adult, pool1	10020-101D2	49.88	16.07	2.18	0.70	0.35	1.14	0.96	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.32	11.92	1.65	0.55	0.18	0.37	0.73	0.37
pancreas, adult, donor1	10049-101G4	66.79	12.23	0.00	0.00	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	28.79	8.67	1.12	0.56	1.96	1.68	1.68	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	27.09	10.73	0.51	0.85	1.02	0.17	0.68	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	35.43	12.75	3.15	0.17	0.17	1.32	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	30.20	86.12	5.03	3.39	1.01	1.65	2.20	0.37
parietal cortex, adult, donor10258	10373-105G4	13.95	49.91	2.94	4.40	2.94	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	26.33	65.83	5.64	1.88	0.94	1.88	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	39.62	128.84	6.27	5.13	1.43	1.71	0.86	0.86
parietal lobe, adult, pool1	10034-101E7	37.72	78.43	4.58	3.97	1.23	2.38	1.15	0.44
parietal lobe, fetal, donor1	10072-101I9	62.07	16.49	2.91	0.00	1.94	0.97	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	13.09	22.06	3.36	1.12	1.12	0.00	0.00	0.75
parotid gland, adult	10199-103F1	57.35	18.50	1.23	1.23	0.00	0.62	1.23	0.00
penis, adult	10200-103F2	41.36	18.26	3.76	0.54	0.54	1.07	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.30	15.80	3.53	0.93	0.37	0.74	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	45.02	13.40	0.44	1.46	1.17	1.17	1.46	0.58
pineal gland - adult, donor10196	10179-103C8	27.74	66.44	10.32	0.00	0.65	1.94	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	67.51	84.09	11.25	1.78	0.59	0.59	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	33.23	27.59	2.51	0.63	2.51	1.25	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	43.51	23.27	2.02	0.00	3.04	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	79.22	42.74	6.78	0.52	2.08	4.69	3.13	0.52
pituitary gland, adult, donor10258	10378-105G9	27.24	17.02	1.70	0.85	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	43.65	35.15	1.51	0.75	1.29	2.47	0.65	2.15
plasma cell leukemia cell line:ARH-77	10840-111E3	35.76	16.02	1.32	0.53	0.13	0.40	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	7.94	9.49	1.09	0.62	0.16	0.47	0.00	0.16
pons, adult, pool1	10033-101E6	31.33	64.03	4.56	4.05	0.60	1.12	0.69	0.52
postcentral gyrus, adult, pool1	10032-101E5	28.51	74.36	4.45	2.70	0.35	1.48	1.05	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	52.28	2.09	8.37	4.18	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	16.52	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	32.34	6.26	1.46	0.44	0.15	0.44	1.17	0.29
prostate cancer cell line:PC-3	10439-106E7	66.25	27.23	5.08	1.09	2.18	1.63	2.18	0.73
prostate, adult, pool1	10022-101D4	60.94	24.94	2.72	0.73	0.27	1.72	1.45	0.36
putamen, adult, donor10196	10176-103C5	38.71	138.57	5.67	3.30	0.47	0.94	2.83	0.47
putamen, adult, donor10252	10152-102I8	19.61	23.53	5.88	0.00	0.00	0.00	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	21.86	3.28	5.46	5.46	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	22.23	61.61	3.87	1.93	1.21	0.00	0.24	0.72
putamen, newborn, donor10223	10365-105F5	8.25	7.50	1.50	0.00	0.75	1.50	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	84.66	33.17	8.44	0.29	3.78	0.87	2.91	2.04
rectum, fetal, donor1	10067-101I4	84.85	23.65	0.00	0.00	0.00	2.78	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	11.87	8.27	0.85	0.64	0.00	0.21	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	13.67	11.60	0.41	0.00	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	53.97	31.61	4.17	0.80	1.89	2.58	1.89	0.89
retinoblastoma cell line:Y79	10475-106I7	30.92	27.02	4.16	3.38	1.56	1.56	1.30	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	31.11	36.76	7.25	3.57	2.21	0.74	0.98	1.97
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	70.58	47.52	6.75	2.53	1.41	1.41	3.09	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	21.98	20.46	1.52	0.76	0.76	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	23.63	12.30	1.62	0.97	0.65	0.65	0.49	0.00
salivary acinar cells, donor2	11772-123I8	26.85	15.97	2.62	0.28	0.55	0.41	1.24	0.55
salivary acinar cells, donor3	11773-123I9	65.54	77.46	7.28	0.66	2.65	0.66	3.31	1.32
salivary gland, adult, pool1	10093-102C3	45.76	31.46	4.00	1.14	0.00	0.57	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.60	14.42	0.42	0.93	0.08	0.00	0.08	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.57	18.10	0.82	0.94	0.35	0.24	0.47	0.12
seminal vesicle, adult	10201-103F3	58.73	23.81	4.76	0.00	1.06	1.06	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.03	6.07	0.24	0.49	1.70	1.94	0.24	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.59	14.09	0.75	0.25	0.75	0.50	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	25.09	31.11	3.01	0.00	0.00	1.00	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.46	14.10	1.21	1.75	1.88	0.94	0.94	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	21.44	14.70	1.77	1.88	0.44	0.22	0.77	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	37.68	18.19	2.97	1.16	1.16	0.90	0.26	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	39.72	15.61	4.26	0.71	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	48.81	12.95	2.16	0.00	0.12	0.60	0.84	0.12
skeletal muscle, fetal, donor1	10066-101I3	49.25	6.03	1.01	0.00	1.01	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	47.50	40.71	0.00	0.00	0.00	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	43.55	11.99	2.52	0.00	3.16	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	40.02	14.01	2.33	2.67	0.33	1.00	1.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	73.13	17.02	3.15	0.95	1.89	5.04	0.95	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	38.74	24.29	2.12	0.58	1.54	0.39	0.77	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	40.71	19.45	3.46	3.63	0.82	1.81	0.66	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	58.23	8.53	2.09	0.48	0.48	1.77	1.61	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	119.42	39.23	9.37	3.70	1.74	0.22	5.23	1.74
small intestine, adult, pool1	10024-101D6	70.59	38.94	5.02	0.96	0.24	1.19	1.55	0.36
small intestine, fetal, donor1	10064-101I1	44.23	14.50	2.21	0.98	0.98	0.98	1.97	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.93	12.31	1.54	0.00	2.05	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	64.36	31.79	2.33	1.03	0.00	1.03	2.84	0.00
somatostatinoma cell line:QGP-1	10781-110G7	59.77	36.99	3.22	0.80	1.88	1.34	1.61	1.61
spinal cord - adult, donor10196	10181-103D1	33.26	26.61	5.51	1.15	1.38	0.92	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	54.80	46.52	4.34	1.18	0.39	1.18	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	18.68	22.14	3.46	1.38	2.08	0.69	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	51.84	27.44	5.49	1.83	0.61	1.83	3.66	0.61
spinal cord, newborn, donor10223	10359-105E8	34.44	17.45	1.38	0.46	0.46	0.92	0.00	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	26.14	19.71	0.45	0.15	0.15	0.15	1.49	0.15
spleen, adult, pool1	10025-101D7	58.81	18.50	1.32	0.77	0.55	0.99	0.88	0.22
spleen, fetal, pool1	10044-101F8	58.32	20.50	2.07	0.87	0.24	0.95	0.79	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	32.81	10.87	1.66	1.66	0.83	0.62	0.41	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	35.13	18.80	3.04	0.76	1.14	1.33	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	33.55	18.17	1.05	1.40	2.45	3.84	2.45	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	50.04	15.25	1.95	1.56	1.56	0.39	2.35	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	45.25	16.66	1.24	1.80	1.91	0.56	1.13	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	8.47	1.69	0.00	1.69	1.27	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.73	16.08	0.00	2.12	1.27	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	65.15	20.29	11.75	1.07	0.00	2.14	5.34	0.00
submaxillary gland, adult	10202-103F4	39.88	18.23	1.14	0.00	0.57	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	59.61	39.26	2.08	1.04	1.25	3.53	3.74	2.08
substantia nigra, adult, donor10258	10371-105G2	11.90	25.86	8.28	2.59	2.07	2.07	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	23.32	8.48	0.00	0.00	2.12	1.41	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	21.55	23.84	3.21	1.15	1.15	1.15	1.38	0.46
temporal lobe, adult, pool1	10031-101E4	27.21	69.17	4.49	2.29	0.76	1.70	0.68	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	49.15	34.90	3.56	0.00	0.71	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	25.05	26.37	3.52	4.83	0.88	3.08	0.00	0.44
tenocyte, donor1	11763-123H8	29.67	19.90	1.75	1.40	0.35	0.35	0.70	0.00
tenocyte, donor2	11765-123I1	13.73	11.06	1.14	0.00	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	18.90	14.09	0.00	0.37	0.37	0.37	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	30.76	27.36	1.36	4.59	2.89	1.36	1.36	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	39.46	9.40	2.00	1.39	1.85	3.08	1.70	0.92
teratocarcinoma cell line:PA-1	10807-111A6	18.60	10.69	1.08	2.79	0.77	1.08	1.08	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	19.93	5.20	0.89	0.89	0.51	1.02	0.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	29.88	6.05	0.76	0.76	1.89	1.89	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	24.98	10.47	1.20	0.87	0.22	0.87	0.98	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.36	2.28	0.98	1.95	5.21	1.63	0.98	3.58
testis, adult, pool1	10026-101D8	35.97	25.23	4.62	0.75	0.97	1.50	1.07	0.64
testis, adult, pool2	10096-102C6	38.79	45.56	9.02	0.90	2.71	2.26	0.00	0.90
thalamus - adult, donor10196	10168-103B6	38.64	37.54	4.42	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	63.45	58.45	2.50	1.25	1.25	2.03	2.50	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	15.40	3.08	3.08	3.08	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.03	9.55	1.65	0.33	0.49	0.82	0.00	0.82
thalamus, newborn, donor10223	10366-105F6	6.33	14.38	4.60	0.58	1.15	0.00	0.00	1.15
throat, adult	10209-103G2	43.44	11.73	1.75	1.00	0.25	0.25	0.50	0.00
throat, fetal, donor1	10061-101H7	53.93	15.24	2.13	0.91	0.61	0.61	2.13	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	18.08	22.85	5.37	1.19	0.20	0.60	0.20	0.60
thymus, adult, pool1	10027-101D9	102.89	23.46	2.39	2.58	1.59	1.09	2.19	1.19
thymus, fetal, pool1	10043-101F7	80.21	24.11	1.66	2.39	0.83	1.25	2.18	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.00	7.71	0.93	1.06	0.40	0.93	0.27	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	56.44	12.85	0.98	3.21	0.42	0.42	3.07	0.00
thyroid, adult, pool1	10028-101E1	56.73	17.08	1.21	0.75	0.19	0.93	1.31	0.28
thyroid, fetal, donor1	10060-101H6	56.42	12.39	1.32	0.26	0.00	0.53	2.90	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	55.43	6.16	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	27.21	13.02	2.09	0.70	2.56	1.16	0.23	0.00
tongue, fetal, donor1	10059-101H5	43.74	8.28	1.18	0.39	0.79	0.79	3.15	0.79
tonsil, adult, pool1	10047-101G2	70.82	31.56	2.91	1.60	1.50	0.80	1.50	0.40
trachea, adult, pool1	10029-101E2	50.14	17.91	1.06	0.74	0.74	1.72	1.23	0.74
trachea, fetal, donor1	10058-101H4	40.78	10.39	0.38	0.00	0.38	1.15	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.42	12.05	1.42	0.00	0.35	0.35	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.15	10.84	1.72	1.22	0.71	0.81	0.81	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	51.08	9.56	2.82	0.78	0.31	1.41	1.10	0.31
tridermal teratoma cell line:HGRT	10694-109G1	60.88	49.47	11.42	3.81	0.00	1.90	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.15	10.92	0.59	0.68	0.93	0.34	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	37.56	4.17	6.26	0.00	0.00	2.09	4.17	0.00
uterus, adult, pool1	10100-102D1	59.55	30.54	2.22	1.54	0.34	1.02	1.54	0.34
uterus, fetal, donor1	10055-101H1	54.78	21.50	0.51	0.00	0.51	0.00	4.10	0.51
vagina, adult	10204-103F6	65.91	23.91	1.94	1.29	0.00	0.65	0.00	2.58
vein, adult	10191-103E2	48.88	17.32	1.75	1.53	0.44	0.66	1.10	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.43	13.89	1.34	1.07	1.07	0.53	0.80	0.00